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 Post-traumatic stress disorder (PTSD) is a debilitating mental disorder precipitated by 
trauma exposure and characterized by involuntary re-experiencing of the traumatic event, 
avoidance of trauma-associated stimuli, negative alterations in mood and cognition, and 
alterations in arousal/reactivity.  While most individuals are exposed to a potentially traumatic 
event at some point in their lives, only a small subset develop PTSD.  This suggests that trauma 
exposure is necessary, but not sufficient, for the pathogenesis of PTSD, and that many other pre-
existing factors, including genetic background, play an influential role in determining individual 
response to trauma.   
PTSD is a complex syndrome with a great degree of heterogeneity in presentation within 
and across populations.  Similarly, biological correlates associated with PTSD, specifically DNA 
methylation (DNAm) and gene expression profiles, exhibit tissue specificity and are comprised 
of two dynamic components: 1) profiles reflecting cellular composition and 2) alterations in 
DNAm levels at CpG sites and transcriptional activity.  In this work, I examine DNA 
methylation and gene expression profiles that reflect the pathophysiology of PTSD while 
considering fundamental population contexts and sources of heterogeneity that have not been 
adequately addressed in the existing PTSD literature – sex, ancestry, and cellular composition.   
After an overview of relevant literature in Chapter 1, the subsequent two chapters 
examine sex-specific profiles associated with PTSD.  Chapter 2 disentangles the contribution of 
cellular composition from DNAm alterations in methylomic profiles to discern sex-specific 
leukocyte composition associated with PTSD using a combined dataset from two independent 
cohorts.  Chapter 3 assesses the relationship between blood and brain transcriptomic profiles in a 
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rat model of PTSD (i.e., individual response to recent trauma exposure) using a publicly 
available expression dataset.  Chapter 4 implements an integrative systems-level approach to 
investigate the genomic context underlying leukocyte methylomic and transcriptomic profiles in 
an understudied, at-risk population of African ancestry, and to identify regulatory epigenetic 
marks that putatively regulate leukocyte gene expression in PTSD.  Chapter 5 provides a 
discussion of the implications of these findings and their contributions to the existing PTSD 
literature.   
This work uses genomic approaches to generate mechanistic hypotheses regarding 
dysregulation observed in PTSD.  It contributes novel insights to the current PTSD literature by 
considering sex-, ancestry-, and cell/tissue-specific contexts, which have historically been 
overlooked, and by doing so provides input for understanding findings that are often inconsistent 
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CHAPTER 1: INTRODUCTION 
 
1.1 Overview 
Post-traumatic stress disorder (PTSD) is a debilitating psychiatric disorder that is 
precipitated by a traumatic event involving direct or indirect exposure to actual or threatened 
death, serious injury, or sexual violence1.  It is characterized by intrusive and persistent re-
experiencing of the traumatic event, avoidance of distressing, trauma-associated stimuli, negative 
alterations in cognition and mood, and alterations in arousal/reactivity that persist for longer than 
a month1.  While most people experience a traumatic event at some point in their lives (~50-90% 
of US population2-4, ~70% world-wide5,6), only a small subset develop PTSD over a lifetime 
(~7% and ~4% lifetime prevalence of PTSD in the US7,8 and across countries5,9, respectively).  
This suggests that exposure to trauma is necessary, but not sufficient, for the development of 
PTSD, and that pre-existing factors, such as genetic background and early life experiences, 
interact with trauma exposure to precipitate a distinct inability to reinstate homeostasis after 
trauma10.   
Epigenetic mechanisms, such as DNA methylation, may serve as a key link between pre-
existing factors and individual response to trauma exposure.  In addition to their role in the onset 
of PTSD, they may continue to play a role in the pathophysiology of the disorder and may even 
continue to influence physiology after the disorder remits, in large part through their influence on 
gene expression profiles, which culminate the effects of functional genetic variants and 
regulatory epigenetic marks and serve as a useful biological readout for understanding the 
pathophysiology of PTSD.   
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However, there are major challenges to understanding PTSD that stem from its 
heterogeneity and evolving definition.  PTSD is a complex syndrome with a great degree of 
heterogeneity in presentation within and across populations, and trauma-exposed individuals 
with vastly distinct symptom presentations can qualify for the same diagnosis of PTSD based on 
the Diagnostic and Statistical Manual, which is revised with each edition11.  This heterogeneity 
in presentation may reflect subtypes of PTSD that vary by extent of dysregulation in implicated 
biological pathways, which in turn may be based on many functional genetic variants of modest 
effects that interact with each other and with an individual’s environmental exposures, 
particularly the causal traumatic event12.  Type, duration, frequency, and intensity of the trauma 
exposure(s), comorbid conditions, as well as interindividual variability in other exposures (e.g., 
chronic stressors, social support) also contribute to the heterogeneity of PTSD12.  Furthermore, 
differences in prevalence and presentation of PTSD have been noted between sexes/genders2-
4,8,13-16 and across racial/ethnic groups17-20, but the biological processes underlying differences 
have not been adequately investigated.   
This dissertation work seeks to address heterogeneity in PTSD that stems from multiple 
sources: sex, tissue, and ancestral background.  Our studies in humans examine the association 
between lifetime PTSD and the immune system, which may reflect longstanding physiological 
changes that occur as a consequence of developing PTSD or a pre-existing physiological 
difference/setpoint associated with greater vulnerability for developing PTSD.  In particular, we 
investigate sex differences in leukocyte composition using methylomic profiles, which may 
reflect sex-specific immune processes – putatively involved in the well-known two-fold higher 
risk of PTSD in females compared to males2-4,8,13-15,21-23.  While profiling from leukocytes in 
peripheral blood may inform our understanding of the systemic nature of PTSD and allow us to 
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investigate the key role of the peripheral immune system in modulating behaviors underlying 
PTSD, the brain is most directly associated with psychiatric symptoms and defining 
manifestations of PTSD.  Since the brain is inaccessible in living humans, we use a rodent model 
of PTSD to investigate the relationship between brain and blood transcriptomic profiles 
associated with individual behavioral differences in response to stress exposure.  The final 
empirical chapter addresses potential genomic sources for the known health disparity in PTSD, 
namely the greater prevalence in African-Americans that exists even when controlling levels of 
trauma exposure18, from a genomic perspective.  We identify PTSD-relevant genetic variants in 
an African-American cohort that may putatively regulate DNA methylation and gene expression 
and investigate the association between differentially methylated CpGs and gene expression in 
lifetime PTSD, thereby elucidating biological sources of increased vulnerability—and 
resilience—to this disorder within an understudied population. 
 
1.2 Societal significance of understanding PTSD 
While PTSD is estimated to rank among the top 20 leading causes of disease burden in 
the general US population24, some argue that the level of disease burden can be considered 
comparable to depression, the second leading cause of disability burden in the world25, when 
work impairment, symptom chronicity, decrement in health status/increased risk of chronic 
disease, drain on healthcare resources, and treatment resistance, are taken into full 
consideration26-28.  Globally, the aftereffects of recent wars, such as the Syrian refugee crisis, 
have highlighted the necessity for considering mental health and post-traumatic psychopathology 
in public policymaking29.  This is particularly pertinent to host countries grappling with the 
challenges of accommodating and quickly integrating a large influx of refugees and migrants, 
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most of whom have experienced traumatic incidents and are at increased risk for developing 
psychiatric disorders, including PTSD30.  While this post-conflict and displacement context 
illustrates an especially substantial disparity between available and needed mental health service 
capacity, mental health services are generally limited in both developing and developed countries 
and require development and implementation of triage systems to prioritize care to those who 
need it most.  Investigation of environmental influences, root causes, and risk and protective 
factors of disorders will enable informed decision making and allow us to work towards 
prevention and early intervention.  This is in fact one of the key research thrusts of the Grand 
Challenges in Global Mental Health initiative, which identified PTSD as a basic and clinical 
research priority for making an impact on population health in both developing and developed 
countries31. 
 
1.3 Sex/gender differences in PTSD: animal and human work 
Epidemiological studies in the general population have consistently shown lifetime 
prevalence of PTSD to be about twice as high in women than men, even when risk of exposure 
and types of trauma are taken into consideration2-4,8,13-15,21-23.  This gender difference in disease 
prevalence is also observed in depression32 and other commonly occurring mood and anxiety 
disorders33.  While women have a significantly higher risk for developing mood and anxiety 
disorders, men have significantly higher risk for impulse-control and substance-use disorders7, 
which suggests the involvement of sexually dimorphic stress response mechanisms and sex 
differences in stress-related dysregulation of involved biological processes and neural circuits.   
In addition to prevalence/conditional risk for developing PTSD, sex/gender differences 
have been reported in other aspects of PTSD, such as 1) chronicity, where women report 
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considerably longer duration of PTSD than men (independent of the type of precipitating 
trauma)3,14; 2) effect of childhood trauma exposure, where females have much higher risk of 
developing PTSD in childhood (≤ 15 years) than males13; 3) nature of co-morbidity with other 
stress-related conditions and disorders, such as depression, where women exhibit a bidirectional 
relationship between PTSD and depressive symptoms (i.e., PTSD symptoms predict later 
depression symptoms, and vice versa), while men only show a significant path from PTSD to 
depressive symptoms34,35; 4) emotional regulation, where women exhibit greater sensitivity to 
and intolerance of negative emotions, while men report greater impulsivity in response to 
emotions16; 5) cognitive symptoms, where women show stronger association with post-trauma, 
dysfunctional beliefs, such as negative appraisals about the self/world and self-blame36, and 
stronger perceptions of threat and loss of control37; and 6) heritability estimates, where women 
have higher heritability estimates for PTSD than men, as supported by twin studies38 and a 
genome-wide association (GWA) study39, which reported molecular-genetics-based heritability 
estimates (h2SNP) to be 29% in females and indistinguishable from 0% in males of European-
American descent . 
Although it is difficult to disentangle gender (i.e., an individual’s self-representation 
based on biology and sociocultural influences) from sex (i.e., an individual’s biological status 
determined most prominently by their DNA) in humans, supporting evidence from animal 
models suggest that there are robust sex differences that contribute to the greater vulnerability of 
women to PTSD and stress-related psychopathology, including sexually dimorphic organization 
of brain circuitry and stress response mechanisms23,40,41.  These sex differences are believed to be 
driven by the organizational and activational effects of gonadal steroid hormones and genes 
(especially those on sex chromosomes) during developmentally sensitive and environmentally 
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responsive periods (i.e., perinatal period and puberty), which shape sexually dimorphic processes 
throughout the lifespan41.   
However, some caveats need to be noted.  While animal models of PTSD42-44, 
predominantly in rodents, have been and will continue to be key for understanding the 
mechanisms underlying biochemical and physiological alterations most directly relevant to 
endophenotypes of PTSD, it is important to consider the translatability and validity of models 
carefully, especially with regards to sex differences.  The majority of animal research on stress 
and PTSD have, unfortunately, been conducted on male animals using stress models developed 
for male animals, which has impeded our progress in understanding the mechanisms underlying 
sex differences45.  Furthermore, while robust sex differences have been observed in the limited 
studies that investigated both sexes, findings have often been inconsistent and correspondence 
with human studies have been ambiguous45,46.  Thus, careful consideration for possible sex 
specificity in animal models and in interpretation of human studies is needed.  Here, I will touch 
on a few findings with supporting evidence in both the animal and human literature that highlight 
the importance of gonadal steroids, genetics, and epigenetics in PTSD. 
Sex-specific mechanisms have been observed in endophenotypes of PTSD – broadly 
divided into dysregulation of fear memory (i.e., fear conditioning and fear extinction)47 and 
stress response41.  Fear extinction, a form of learning involved in the suppression of learned fear 
responses, is the basis of exposure-based cognitive behavioral therapy (CBT) and has been found 
to be modulated by circulating gonadal hormones, especially estrogen in females48,49.  Fear 
extinction learning during high ovarian hormone levels (i.e., proestrus phase or hormone 
injection prior to learning in metestrus phase) was determined to be more fully consolidated (i.e., 
low freezing during recall), while fear extinction during low ovarian hormone levels (i.e., 
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metestrus phase or estrogen/progesterone receptor blockade during proestrus) impaired 
extinction consolidation (i.e., significantly higher freezing during recall)50.  Another study 
further revealed that estrogen plays a more prominent role than progesterone in fear extinction, 
specifically through estrogen receptor beta51.  Follow-up studies in humans were consistent with 
these findings and showed that higher estradiol during extinction learning enhanced extinction 
recall, while low levels impaired this process52.  Furthermore, low estradiol levels have been 
linked with fear extinction deficits in women with PTSD, but not in women without PTSD48,53, 
suggesting estrogen may be a promising therapeutic adjuvant for use during exposure-based CBT 
in women with PTSD.   
More recently, a study explored the genetic and epigenetic context behind estrogenic 
mediation of fear regulation in women with PTSD, with supporting evidence in a rodent model54.  
They found significant overlap between CpG sites associated with PTSD and those that 
associated with serum estradiol levels at nominal significance, supporting an epigenetic link 
between estradiol-mediated signaling and PTSD in women.  The most robust finding revealed 
higher methylation of CpG sites in the histone deacetylase 4 (HDAC4) gene in blood samples of 
PTSD cases than controls, with significance remaining in cg22937172 after Bonferroni 
correction.  Higher methylation at this site was also associated with lower serum estradiol levels.  
Additionally, this CpG region is found near binding sites for glucocorticoid and estrogen 
receptors and a common single nucleotide polymorphism (SNP), rs7570903.  The C/C genotype 
at this SNP was found to be associated with higher cg22937172 methylation and lower HDAC4 
expression levels.  Since HDAC4 is involved in long-term memory processes, further follow-up 
determined the relationship between genetic variation at this locus and fear-related traits in both 
human and animal models.  Women with the C/C genotype at rs7570903 showed enhanced fear 
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expression and this genotype interacted with PTSD diagnosis to predict increased fear 
conditioning and higher fear-potentiated startle during early extinction.  Neuroimaging 
assessment of highly traumatized women revealed that this risk genotype is associated with 
increased resting-state functional connectivity between the amygdala and cingulate cortex, which 
are brain regions implicated in fear memory.  Additionally, auditory fear conditioning increased 
Hdac4 expression in amygdala of ovariectomized and low estrogen (metestrous) cycle, but not 
high estrogen (proestrous) cycle female mice, relative to homecage controls.  In all, this study 
supported a mediating role for estrogen in the regulation of HDAC4 expression, which is 
associated with fear learning processes and may contribute to PTSD in women.  It illustrated the 
genetic and epigenetic context by drawing associations between a genetic risk variant and DNA 
methylation mark that regulate HDAC4 expression in blood with fear regulation and estrogen 
levels.   
In addition to its significant mediating role in fear learning, gonadal hormones have also 
been implicated in the regulation of sex-specific stress response mechanisms in PTSD, which are 
largely thought to be mediated by the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-
pituitary-gonadal (HPG) axes55-57.  Of note, a functional SNP variant (rs2267735) in a putative 
oestrogen response element within the ADCYAP1R1 gene was associated with PTSD diagnosis, 
PTSD symptoms, and fear discrimination (i.e., fear potentiated startle), and showed a strong 
association between PTSD symptom severity and genotype by trauma exposure interaction only 
in women58,59.  The ADCYAP1R1 gene encodes the pituitary adenylate cyclase-activating 
polypeptide (PACAP/PAC1) receptor, which interacts with PACAP to regulate neuroendocrine 
stress circuits and cellular stress response60,61.  Sex-specific effects of this regulatory system 
were reported in both brain and blood59.  In the brain, a sex-by-genotype interaction was found to 
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regulate ADCYAP1R1 expression (i.e., mRNA levels), such that females with the C/C genotype 
expressed significantly less ADCYAP1R1 than males or females with the C/G genotype.  In 
blood, PACAP levels were associated with fear physiology, PTSD diagnosis, and symptoms, in 
heavily traumatized women.  Additionally, in rodent models, fear conditioning and oestrogen 
replacement were found to induce ADCYAP1R1 mRNA expression in amygdala and bed 
nuclease of stria terminalis (BNST), respectively, providing further evidence for the role of 
estrogen in stress response via regulation of the ADCYAP1R1 gene59.  Finally, while not as fully 
explored, a SNP (rs523349) in the SRD5A2 gene, which encodes steroid 5-α-reductase type 2, 
was associated with PTS symptom severity and risk for PTSD only in men62, and is suspected to 
differentially regulate stress and sex steroid metabolism (for testosterone, cortisol, and 
progesterone) between sexes.  So far, sexually dimorphic stress-response mechanisms are largely 
attributed to the crosstalk between glucocorticoid receptors and estrogen receptors63.   
However, immune signaling is also a key domain in the study of sex differences in 
PTSD.  Like sex differences in brain circuitry and stress response mechanisms, prominent 
immunological sex differences are also mediated by genes, hormones, and environmental 
exposures64, and may play a key role in sex-specific brain development implicated in sexually 
dimorphic stress response and vulnerability for psychiatric disorders65.  So far, work at the 
intersection of stress and psychoneuroimmunology has focused on male animals and sex 
differences in stress-related neuroinflammation have not been explored.  Similarly, investigation 
of sex differences in the PTSD transcriptomic literature, which is largely based on blood tissue 
(e.g., leukocytes, PBMCs), is sparse.  Two studies that isolated CD14+ monocytes from 
peripheral blood noted sex differences in transcriptional regulation and gene expression 
associated with chronic PTSD in monocytes66,67.  In contrast, a recent mega-analysis of the 
10 
 
PTSD blood transcriptome that considered sex and type of traumatic event in co-expression 
network analyses reported some distinct gene expression perturbation modules, but generally a 
high degree of sharing of transcriptional dysregulation across sex and modes of trauma in PTSD, 
converging on common signaling cascades, including cytokine, innate immune, and type I 
interferon pathways68.  Further investigation of sex differences in immune dysregulation is 
warranted. 
Investigating sex-specific trajectories of the brain and immune system across the lifespan, 
particularly in the context of stress and trauma, may help inform how the crosstalk between the 
brain and immune system influence sex differences in behavior and vulnerability/resilience for 
PTSD and other stress-related disorders.  It will allow discovery of robust predictive biomarkers 
that can be used for implementing early interventions, and development of improved, and 
possibly sex-appropriate preventative or therapeutic strategies.  This, in turn, has immense 
implications for reducing stress-related disease burden. 
 
1.4 Racial/ethnic disparities in PTSD 
Lifetime prevalence of PTSD differs across racial/ethnic groups and is higher among at-
risk minority groups, including African-Americans (AA) and Latinos, compared to 
Caucasians14,18,69-71.  This health disparity may reflect biological as well as interrelated 
sociocultural differences, which include differences in trauma exposure, socioeconomic status 
(e.g., education, income, employment status), access to health care/treatment seeking behavior, 
discrimination, and cultural factors (e.g., reporting style, cultural interpretations of symptoms 
and distress, coping styles)17.  Indeed, at-risk ethnic minorities, most notably economically 
disadvantaged AAs living in urban settings, have higher levels of trauma exposure, particularly 
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assaultive violence, compared to Caucasians14,19,72,73.  However, the higher lifetime prevalence 
and conditional risk of PTSD in AAs compared to Caucasians, is not entirely accounted for by 
differences in trauma exposure, suggesting biological and environmental risk factors, such as low 
socioeconomic status and racial discrimination, may account for this disparity18.   
Racial/ethnic differences have also been reported in the expression and severity of PTSD 
symptoms, the course of disease, and the magnitude of associations between PTSD and chronic 
medical conditions, such as diabetes17,20,74-76.  While these differences have largely been 
attributed to sociocultural risk factors in epidemiological studies, the biological mechanisms by 
which these sociocultural determinants translate into health disparities, are largely unknown.  
The concept of allostatic load models sociocultural risk factors as chronic exposure to social and 
environmental stressors that lead to accumulation of “wear and tear” in the body, which 
manifests as physiological changes that increase vulnerability to disease and stress-related 
psychopathology among socially disadvantaged groups, including at-risk racial/ethnic 
minorities77-79.  Thus, racial/ethnic disparities in PTSD may be attributable to a larger allostatic 
load driven by higher exposure to social adversity in these at-risk groups.   
These racial/ethnic differences in allostatic load may contribute to racial/ethnic 
differences in gene-by-environment (GxE) interactions and epigenetic processes.  Higher 
allostatic load due to social adversity in at-risk groups is likely to be reflected in epigenetic 
processes that biochemically encode these exposures into the genomic architecture of each cell to 
modulate gene expression, and, by extension, cell functioning and phenotype.  Similarly, higher 
allostatic load may also interact with functional genetic variants to moderate risk for, or 
resilience to, development of PTSD.  While biological mechanisms underlying the regulatory 
effect of genetic variants are likely to be shared, the allele frequency of genetic variants may 
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differ greatly across different racial/ethnic groups80.  This means PTSD-associated functional 
genetic variants with different allele frequencies across populations may be more relevant for 
some racial/ethnic groups than others.  Further studies that explore the role of GxE and 
epigenetic processes in the development and pathophysiology of PTSD should consider the 
implications of these various racial/ethnic differences. 
 
1.5 Summary 
This work uses genomic approaches to generate mechanistic hypotheses regarding 
dysregulation observed in PTSD.  It contributes novel insights to the current PTSD literature by 
considering sex-, ancestry-, and tissue-specific contexts, which have largely been overlooked, 






CHAPTER 2: METHYLOMIC PROFILES REVEAL SEX-SPECIFIC LEUKOCYTE 
COMPOSITION ASSOCIATED WITH PTSD1 
 
2.1 Abstract 
Post-traumatic stress disorder (PTSD) is a debilitating mental disorder precipitated by 
trauma exposure.  However, only some persons exposed to trauma develop PTSD.  There are sex 
differences in risk; twice as many women as men develop a lifetime diagnosis of PTSD.  
Methylomic profiles derived from peripheral blood are well-suited for investigating PTSD 
because DNA methylation (DNAm) encodes individual response to trauma and may play a key 
role in the immune dysregulation characteristic of PTSD pathophysiology.  In the current study, 
we leveraged recent methodological advances to investigate sex-specific differences in DNAm-
based leukocyte composition that are associated with lifetime PTSD.  We estimated leukocyte 
composition on a combined methylation array dataset (483 participants, ~450k CpG sites) 
consisting of two civilian cohorts, the Detroit Neighborhood Health Study and Grady Trauma 
Project.  Sex-stratified Mann-Whitney U test and two-way ANCOVA revealed that lifetime 
PTSD was associated with a small but significant elevation in monocyte proportions in males, 
but not in females (Holm-adjusted p-val < 0.05).  No difference in monocyte proportions was 
observed between current and remitted PTSD cases in males, suggesting that this sex-specific 
difference reflects a long-standing trait of lifetime history of PTSD, rather than current state of 
PTSD.  Associations with lifetime PTSD or PTSD status were not observed in any other 
leukocyte subtype and our finding in monocytes was confirmed using cell estimates based on a 
                                                 
1 This chapter is available on bioRxiv preprint (10.1101/594127) and is under review at Brain, Behavior, and 
Immunity.   
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different deconvolution algorithm, suggesting that our sex-specific findings are robust across cell 
estimation approaches.  Overall, our main finding of elevated monocyte proportions in males, but 
not in females with lifetime history of PTSD provides evidence for a sex-specific difference in 
peripheral blood leukocyte composition that is detectable in methylomic profiles and that reflects 
long-standing changes associated with PTSD diagnosis. 
 
2.2 Introduction 
Post-traumatic stress disorder (PTSD) is a debilitating mental disorder that is precipitated 
by a traumatic experience involving direct or indirect exposure to actual or threatened death, 
serious injury, or sexual violence1.  PTSD presents with intrusive and persistent re-experiencing 
of the traumatic event, avoidance of distressing, trauma-associated stimuli, negative alterations in 
cognition and mood, and alterations in arousal/reactivity that persist for longer than a month1.  
While most individuals are exposed to a potentially traumatic event at some point in their lives, 
only some develop PTSD2-8, suggesting that the disorder reflects a distinct inability to reinstate 
homeostasis after psychological trauma in vulnerable individuals10.   
Epidemiological studies have identified sex to be a significant vulnerability factor for 
developing PTSD, with women twice as likely to have lifetime PTSD than men, even when risk 
of exposure and types of trauma are taken into consideration3,4,8,13-15.  This sex bias in disease 
prevalence is also observed in other stress-related mood and anxiety disorders33, including 
depression32.  Preclinical and clinical investigations have identified sexual dimorphism in stress 
response systems that may be involved in the increased prevalence of stress-related 
psychopathologies in women23,40.  Furthermore, in addition to sexual dimorphism in the 
neurobiological underpinnings of stress/trauma response, recent animal studies suggest that 
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behavioral response to traumatic stress is fundamentally different between males and females 
and should be considered in interpretation of results81.  In humans, response to stress/trauma 
exposure involves both biological and social contributors corresponding to sex and gender-
related variables.  While the effects of sex and gender are difficult to disentangle, investigations 
stratified by biological sex, understood to interact with gender-related variables, are warranted to 
improve our currently limited understanding of the sex-specific biological processes 
dysregulated in PTSD pathophysiology.    
Mounting evidence suggests a key role for stress-induced inflammation and immune 
alteration in the development and maintenance of PTSD and other stress-related psychiatric 
disorders.  Although findings from human literature have been mixed, PTSD has generally been 
associated with increased pro-inflammatory tone, basally and in response to immune challenge, 
via both cytokine signaling and changes in immune cell distribution/function82-98.  Investigations 
in animal models, primarily in male rodent studies, have provided mechanistic insights into how 
peripheral immune cell response/signaling and distribution is linked with microglial activation 
and neuroinflammatory dynamics to trigger stress-induced anxiety behavior and memory 
impairment99-105.   
Epigenetic mechanisms have emerged as important regulators of PTSD-associated 
immune dysregulation and inflammation106-111, and are particularly significant for the study of 
PTSD because they capture the interactions among pre-disposing genetic/environmental risk 
factors and the precipitating trauma exposure.  Individual response to trauma exposure can be 
encoded as short-lived or persistent epigenetic changes that reflect and may contribute to 
posttraumatic physiological changes, some of which remain after remission of PTSD symptoms.  
DNA methylation (DNAm) has been the most widely studied epigenetic mechanism and 
16 
 
evidence from both animal and human models point to its key role in stress regulation10,112-114, 
fear memory115-119, and immune function108-111,120-123, in both brain and blood.  Exploring PTSD-
associated DNAm profiles in blood may inform our understanding of mechanisms underlying 
immune dysregulation, particularly those that coordinate peripheral immune-neuroimmune 
crosstalk124,125, and given the well-known sex difference in PTSD prevalence and in immune 
response64,126, sex-stratified investigation is warranted.   
Peripheral blood-based methylomic profiles are comprised of two dynamic components: 
1) profiles reflecting proportions of immune cell subtypes (i.e., leukocyte composition) and 2) 
alterations in DNAm levels at CpG sites genome-wide (i.e., differential methylation).  
Epigenome-wide association studies (EWAS) often seek to identify dynamic differential 
methylation marks and treat cellular heterogeneity as a major confound that must be addressed to 
improve signal detection.  However, differences in leukocyte subtypes provide key insights into 
immunological changes and warrant examination themselves.  Recent developments in 
deconvolution algorithms and cell-type discriminating reference databases have improved 
estimates127-130 and enabled utility of DNAm-based leukocyte subtype estimates as proxies for 
white blood cell differential-based metrics131,132.  Leveraging these recently developed methods, 
here we use leukocyte-derived methylomic profiles combined from two civilian cohorts to 
investigate our hypothesis that PTSD is associated with sex-specific differences in leukocyte 
composition, detectable by DNAm-based estimates.  To our knowledge, this study is the first to 
investigate leukocyte composition profiles in PTSD using these new DNAm-based approaches 






Samples from trauma-exposed, adult participants with available Illumina 
HumanMethylation450 (450K) BeadChip array data were selected from two predominantly 
African-American, community-based cohorts examining biological and environmental correlates 
of PTSD, namely the Detroit Neighborhood Health Study (DNHS; n=192) and Grady Trauma 
Project (GTP; n=422).  The DNHS, based in Detroit, MI, was approved by the institutional 
review boards of the University of Michigan and University of North Carolina at Chapel Hill.  
The GTP, based in Atlanta, GA, was approved by the institutional review boards of Emory 
University School of Medicine and Grady Memorial Hospital.  All participants provided written 
informed consent prior to data collection.  Details regarding the DNHS73,108,133 and GTP72,134,135 
were published previously.  While neither study excluded participants based on illness, women 
known to be pregnant (in the GTP) were excluded from estimation and analyses, due to well-
known/known significant differences in leukocyte composition during pregnancy136.  Collected 
demographic data included self-reported gender, race, age, and current smoking, which was 
defined as any cigarette smoking in the past 30 days.  
 
Assessment of PTSD 
Study participants were assessed for PTSD, as defined by the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (DSM-IV)137.  In the DNHS, study participants were 
assessed for PTSD using the well-validated self-report PTSD Checklist, Civilian Version (PCL-
C)138-141 and additional questions about duration, timing, and impairment due to symptoms, via 
structured telephone interviews14,108,142.  Participants who met all six DSM-IV criteria in 
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reference to their worst traumatic event or to a randomly selected traumatic event (if the 
participant experienced more than one trauma), were considered affected by lifetime PTSD.  
Those that met criteria based on symptoms reported within the past month were considered 
affected by current PTSD. Analysis of data from the clinical interviews showed that the PTSD 
instrument used during structured telephone interviews had excellent internal consistency and 
high concordance108,143. The PCL-C yielded a Cronbach coefficient alpha (α) of 0.93. Using 
cluster scoring based on DSM-IV criteria (i.e. to be a case, the participant’s symptoms had to 
meet all six criteria), the instrument had a specificity (SP) of 0.97, sensitivity (SE) of 0.24, 
positive predictive value (PPV) of 0.80, negative predictive value (NPV) 0.72, and an area under 
the ROC curve (AUC) of 0.76, as previously reported108,143.  In the GTP, 144study participants 
were assessed for lifetime and current PTSD using the Clinician‐Administered Post‐traumatic 
Stress Disorder Scale (CAPS, DSM-IV), a structured interview administered by a clinician that 
has previously been shown to have excellent reliability (i.e., consistent scores across items, 
raters, testing occasions) and excellent convergent and discriminant validity in large scale 
psychometric studies145,146.  For lifetime analyses, participants meeting criteria for PTSD at any 
point (including current and past PTSD) were considered cases and compared to trauma-exposed 
controls who lacked a history of PTSD at any point in their lifetime. For comparisons of current 
PTSD with remitted PTSD and trauma exposed controls, participants with lifetime PTSD were 
further separated into two groups: those with current PTSD and those with lifetime (but not 







In the DNHS, samples were obtained via an in-home blood draw performed by a 
clinician, processed in the lab within two hours, and stored at -20°C until testing.  Detailed 
methods regarding biospecimen processing in the DNHS are available in a separate 
publication147.  In the GTP, DNA was extracted from whole blood, aliquoted and frozen at -80°C 
within two hours of collection.  Genomic DNA was extracted from peripheral blood using the 
DNA Mini Kit (Qiagen, Germantown, MD) in the DNHS and the Gentra Puregene Kit (Qiagen, 
Germantown, MD) in the GTP.  Both studies bisulfite-converted the DNA samples using the 
Zymo EZ-96 DNA methylation kit (Zymo Research, Irvine, CA) and used 500 ng of DNA per 
sample for whole-genome amplification, fragmentation, and hybridization to the Illumina Human 
Methylation 450K BeadChip array (Illumina, San Diego, CA), according to the manufacturers’ 
recommended protocols.  Sample processing procedures have been published previously for both 
the DNHS and GTP123,135,148-150. 
 
Quality control and pre-processing of 450K Data 
The raw .idat files were imported into R (version 3.5.1)151, using the minfi152 
Bioconductor (version 3.7)153,154 package, for all subsequent data processing and analyses.  After 
quality control (QC)152,155,156, data pre-processing157-162 was conducted on all QC’ed samples 
(DNHS: n = 187; GTP: n = 416).  This included duplicates (n=12) in the DNHS and participants 
with known pregnancy (n = 26) or missing PTSD phenotype data (n = 82) in the GTP.  Analyses 
were conducted on unique participants that passed QC, as described below, and had PTSD data 
available (Table 2.1).   
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For data quality assessment, samples were checked for 1) low total signal (mean signal 
intensity less than half of the overall median, after setting probes with detection p-value > 0.001 
or < 2,000 arbitrary units to missing); 2) > 1% of failed probes (detection p-value > 0.001); 3) 
outlying beta value distribution (i.e., smaller than three times interquartile range (IQR) from the 
lower quartile or larger than 3 times IQR from the upper quartile); 4) greater than three standard 
deviations of the mean bisulfite conversion control probe signal intensity130.  Additionally, 
samples were checked for gender discordance based on median total intensity of X and Y-
chromosome mapped probes (as implemented in minfi152) and removed if predicted sex differed 
from self-reported gender.  Five samples were removed among DNHS samples for gender 
discordance, and six samples were removed among GTP samples (two for data quality and four 
for gender discordance).  After within-array background correction and dye-bias equalization 
using out-of-band control probes (ssNoob158,163; minfi), probes with detection p-value > 0.001 in 
more than 10% of samples155 and cross-reactive probes159 (i.e., cross-hybridized between 
autosomes and sex chromosomes) were removed.  Beta-mixture quantile (BMIQ) normalization 
(ChAMP161,162) was used to correct for type II probe bias160.   
To control for technical artifacts (e.g., sample processing and imaging batch effects), 
principal components (PCs) based on non-negative control probe signal intensity156 were 
removed from BMIQ-normalized M-values (i.e., logit-transformed beta-values) separately for 
each study.  PC correlation heatmaps were used to check for successful removal/reduction of 
batch effects, especially chip and row effects, while maintaining signal from biological variables.  
The DNHS and GTP datasets were then combined and an empirical Bayes method (i.e., 
ComBat164 in the sva package165) was used on the combined M-values to account for study 
effects while controlling for sex and age.  Data quality assessment, QC probe filtering, and first 
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step of batch removal were study-specific, while pre-processing steps (ssNoob+BMIQ) 
implemented within-array approaches unaffected by study.  Only probes that passed QC in both 
studies (n = 455,072 probes) were included in the combined dataset.   
 
Leukocyte Composition Estimation 
Leukocyte composition was estimated on ComBat-adjusted beta-values using the 
EpiDISH128 reference database, which is informed by cell-type specific DNase hypersensitive 
sites (DHS; based on the NIH Epigenomics Roadmap database166) and is optimized for 
discriminating granulocytes, CD14+ monocytes, CD8+ T cells, CD4+ T cells, CD19+ B cells, and 
CD56+ natural killer cells.  Robust partial correlation (RPC; robust multivariate linear regression, 
non-constrained projection) was used as the primary deconvolution algorithm and EpiDISH’s 
implementation of linear, constrained projection (CP), originally introduced by Houseman et al. 
(2012)167, was used to calculate a second set of estimates for comparison.   
 
Ancestry Estimation 
 DNAm-based ancestry PCs were derived on cleaned beta-values after regressing out sex 
and age from batch-adjusted M-values.  Ancestry PCs were calculated on a subset of 2,317 
ancestry informative CpG probes included in two published ancestry informative CpG lists that 
accounted for confounders168 and that included probes within 10 base pairs (bp) of single 
nucleotide polymorphisms (SNPs)169.  The first 2 PCs based on this subset of probes were used 
as ancestry PCs (ancPCs) after checking for strong association with self-reported race and 






The Shapiro-Wilk test was used to assess normality and Levene’s test was used to 
compare equality of variance among groups.  Since cell estimates had dissimilar, non-normal 
distributions, non-parametric tests were used for all initial group comparisons of leukocyte 
subtypes.  The two-sample Kolmogorov-Smirnov (KS) test was used to compare distribution of 
cell estimates when variances were unequal between groups and Mann-Whitney U test was used 
to compare mean ranks of cell estimates otherwise.  Spearman’s rank correlation was used to 
assess agreement between estimates based on RPC and CP deconvolution approaches.  A 
threshold of 0.05 was used for p-values and p-values were adjusted for multiple comparisons 
using Holm’s method170, unless otherwise specified.   
To test our main hypothesis—that PTSD is associated with sex-specific differences in 
leukocyte composition—initial sex-stratified analyses were conducted on all leukocyte subtypes 
using the non-parametric Mann-Whitney U test.   For leukocyte subtypes determined to be 
significantly associated with lifetime PTSD in either sex based on initial Mann-Whitney U tests, 
a two-way analysis of covariance (ANCOVA; Type III) controlling for age, ancestry (based on 
DNAm ancestry PCs), and current smoking, was performed with post-hoc comparison of 
estimated marginal means to examine the effects of sex and lifetime PTSD on transformed cell 
estimates.  Transformation for cell estimate was conducted to meet modeling assumptions for 
ANCOVA and was informed by Tukey’s Ladder of Powers.  Power parameter (λ) was computed 
to maximize normality based on the Shapiro-Wilks W statistic.  Sex-stratified Kruskal-Wallis 
and post-hoc Dunn tests were conducted as additional follow-up to investigate possible 
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differences in cell proportions by PTSD status (i.e., trauma-exposed controls, remitted PTSD, 
and current PTSD). 
2.4 Results 
Demographic characteristics of sampled study participants from the DNHS and GTP 
The demographic characteristics of study participants included in primary analyses 
investigating sex-specific associations between DNAm-based cell estimates and lifetime PTSD 
are presented in Table 2.1.  Of the 483 participants from the combined DNHS and GTP sample, 
57.3% had a lifetime diagnosis of PTSD, 68.3% were female, and 38.7% were current smokers.  
The study population was predominantly African-American (89.2%), based on self-reported 
race, and the median age was 48 years (IQR: 17.5; 37.5-55 years).   
 
Comparison of leukocyte subtype estimates by deconvolution approach 
Good overall agreement was observed between RPC and CP estimates, as measured by 
Spearman’s correlation (i.e., RPC-CP correlation), but CD8T cells showed much poorer 
agreement, ρs(481) = 0.83,  relative to the other leukocyte subtypes, ρs(481) > 0.94 (Figure 2.1).  
Since the main objective of this study was to investigate sex-specific differences in leukocyte 
composition, comparison of RPC and CP estimates was stratified by sex.  Sex-stratified RPC-CP 
correlation revealed that the largest difference in RPC-CP correlation between sexes was also 
found in CD8T cells, |∆ρs| = 0.07, such that females showed poorer correlation, ρs(328) = 0.80, 
than males, ρs(151) = 0.87.  For the other leukocyte subtypes, the difference in RPC-CP 
correlation between sexes (|∆ρs|), ranged from 0.01 to 0.03, with CD56
+ natural killer (NK) cells 
having the second largest difference in correlation between sexes (female: ρs(328) = 0.93; male: 
ρs(151) = 0.96).  In all leukocyte subtypes, except CD19
+ B cells, females had lower correlation 
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coefficients than males.   Detailed results for RPC-based cell estimates are reported below and 
corresponding results based on CP-based estimates are reported in Appendix A - Supplementary 
Materials, due to strong agreement between findings from both sets of estimates.   
 
Comparison of leukocyte subtype estimates by sex and lifetime PTSD  
Cell estimates were compared by sex, lifetime PTSD, and study in each leukocyte 
subtype to establish overall differences.  Significant overall sex differences were observed in the 
distributions of CD56+ natural killer (NK) cell (KS: D = 0.19, adj. p = 0.007) and CD8+ T cell 
(CD8T) proportions (KS: D = 0.16; adj. p = 0.04) in RPC estimates.  Males showed greater 
variability than females for both NK and CD8T cells (male vs. female - IQRNK: 6.2% vs. 4.15%; 
IQRCD8T: 9.5% vs. 6.2%), as well as higher median NK (5.5% vs. 4.4%) and lower median 
CD8T (9.0% vs. 9.7%) cell proportions (Figure 2.2).  No significant overall differences (i.e., in 
both sexes combined) were observed between lifetime PTSD cases and trauma-exposed controls 
in any leukocyte subtype (Mann-Whitney).  Additional analyses comparing leukocyte subtype 
proportions between participating cohorts and assessing age effects in each cell type are reported 
in Appendix A.   
 
Elevated monocyte proportions were associated with lifetime PTSD in males, but not females  
Sex-stratified Mann-Whitney U tests revealed a significant difference in monocyte 
proportions between PTSD cases and controls in males (Figures 2.3 and 2.4).  Males with 
lifetime PTSD had higher median monocyte proportions than trauma-exposed controls, U = 
2100, Z = -2.9, p = 0.004, adj. p = 0.026, r = 0.23.  In contrast, no difference in monocyte 
estimates was found between groups in females, U = 13000, Z = -0.58, p = 0.6, adj. p = 1, r = 
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0.03.  Lifetime PTSD-associated differences were not observed in any other leukocyte subtypes 
in either sex.   
A two-way ANCOVA was conducted to investigate whether sex moderated the effects of 
lifetime PTSD on transformed monocyte estimates, while accounting for age, ancestry, and 
current smoking (Table 2.2).  Monocyte estimates were square root transformed for the 
ANCOVA to meet model assumptions (i.e., normality) and were informed by Tukey’s Ladder of 
Powers (RPC: λ = 0.43; CP λ = 0.5).  A significant interaction was found between sex and 
lifetime PTSD, F(1, 461) = 4.89, p = 0.027, ηp
2 = 0.011.  Post-hoc comparison of estimated 
marginal means (EMMs) for lifetime PTSD by sex (Figure 2.5; Table 2.3) showed a significant 
mean difference between lifetime PTSD cases and controls in males, ∆EMM = 0.26, SE = 0.08, 
t(461) = 3.32, p = 0.001, where mean monocyte estimates were higher in lifetime PTSD cases 
than controls.  No significant mean difference was observed between PTSD cases and controls in 
females, ∆EMM = 0.05, SE = 0.05, t(461) = 0.89, p = 0.37, confirming findings from initial sex-
stratified analyses.  Together, our results suggest that male PTSD cases have significantly 
elevated monocyte proportions compared to trauma-exposed controls and that this lifetime 
PTSD-associated difference is not observed in females.   
 
Association between monocyte proportions and lifetime PTSD in males is independent of current 
PTSD status 
To investigate whether participants with current PTSD exhibited a different monocyte 
profile from those with remitted PTSD, a sex-stratified Kruskal-Wallis test was conducted for 
PTSD status (i.e., trauma-exposed controls, remitted PTSD, and current PTSD; Figure 2.6).  A 
significant difference in monocyte estimates was observed in males, H(2) = 8.2, p = 0.017, but 
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not in females, H(2) = 1.1, p = 0.59, confirming findings from analyses for lifetime PTSD.  The 
post-hoc Dunn test revealed significant differences between PTSD case groups and trauma-
exposed controls (current PTSD vs. controls: Z = 2.31, p = 0.021, adj. p = 0.042, r = 0.23; 
remitted PTSD vs controls: Z = 2.40, p = 0.016, adj. p = 0.049, r = 0.22), but no significant 
difference between current and remitted PTSD groups, Z = 0.18, p = 0.86, adj. p = 0.86, r = 0.02.  
These findings suggest that the association between monocyte proportions and lifetime PTSD in 
males is independent of current PTSD state and may reflect long-standing changes associated 
with lifetime history of PTSD diagnosis.    
Comparative analyses based on CP monocyte estimates showed similar results to RPC-
based results (see Appendix A - Supplementary Materials); however, CP-based results 
consistently presented smaller effect sizes than RPC-based results across all analyses and follow-
up comparisons between PTSD case groups and trauma-exposed controls did not reach 




Methylomic profiles derived from peripheral blood offer a wealth of information and can 
be harnessed to detect two dynamic measures of immune state: 1) differences in leukocyte 
composition (i.e., proportions of peripheral immune cell subtypes); and 2) true alterations in 
methylation involved in epigenetic regulation of immune processes.  They are particularly well-
suited for investigating PTSD because DNAm encodes individual response to trauma and may 
play a key role in PTSD-associated immune dysregulation.  Given the prominent sex differences 
in both PTSD prevalence3,4,8,13-15 and immune response64,126, the primary goal of the present 
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study was to investigate whether PTSD is associated with sex-specific differences in leukocyte 
composition, detectable by DNAm-based estimates.  We found that lifetime PTSD was 
associated with a small but significant elevation in monocyte proportions in males, but not 
females.  No difference in monocyte proportions was observed between current and remitted 
PTSD cases in males, suggesting that this sex-specific difference reflects a long-standing trait of 
lifetime history of PTSD diagnosis, rather than current state of PTSD.  These findings were 
observed in both the primary RPC and comparison CP-based sets of cell estimates, which were 
derived using non-constrained vs. constrained projection deconvolution algorithms, respectively.  
Overall, our main finding of elevated monocyte proportions in males, but not females with 
lifetime history of PTSD provides evidence for a sex-specific difference in peripheral blood 
leukocyte composition that likely reflects long-standing changes associated with PTSD diagnosis 
and is detectable in methylomic profiles, consistently across different deconvolution algorithms.   
In our study, we leveraged recent advances in reference-based deconvolution methods128-
130 – specifically the EpiDISH algorithm128, which (i) employs DNase hypersensitive site (DHS) 
data of leukocyte subtypes to inform probe selection for their reference database and (ii) 
introduces RPC, a non-constrained projection approach for reference-based deconvolution.  A 
comparative validation study on in-silico mixtures of purified cell DNAm profiles previously 
showed this newer RPC approach to consistently perform better than the widely used CP 
approach167, based on root mean square error (RMSE) and R2, at low noise levels128 typically 
encountered in real data128,130.  Relevant to our results, the study showed the difference in RMSE 
and R2 to be the most prominent in CD8T cells128.  This is consistent with our comparison 
between RPC and CP estimates, which showed CD8T cells to exhibit poorer correlation between 
RPC and CP estimates relative to other leukocyte subtypes and the largest difference in RPC-CP 
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correlation between sexes.  Similarly, the validation study reported better performance of RPC, 
compared to CP, in monocytes, with higher RMSE and lower R2 in CP compared to RPC, 
suggesting RPC-based estimates were more robustly associated with true weights.  In light of the 
validation study, this suggests that our RPC-based estimates were better able to resolve male-
specific association of monocyte proportions with lifetime PTSD.  In all, our results were 
consistent with the previously published validation study128 and favored use of RPC estimates for 
modeling leukocyte composition.  However, as these methods have been developed recently, 
further validation and comparative studies are warranted.   
Comparison of leukocyte subtype estimates by sex revealed significant baseline sex 
differences in the distributions of NK cell and CD8T cell proportions, with males showing 
greater median NK and lower median CD8T cell proportions, using both RPC and CP based 
estimates.  This finding is consistent with a previous study that reported sex differences in both 
leukocyte subtypes using estimates based on minfi’s implementation of the Houseman 
approach171 and with immunology literature that reported higher NK cell counts and proportions 
in males compared to females172.  A recent study that modeled cell-specific methylation profiles 
also reported robust sex differences in CD56+ NK methylation patterns173, suggesting that this 
leukocyte subtype may be regulated by DNAm in a sex-specific manner.  Additionally, DNAm 
dynamics have been found to drive effector functions in CD8T cells after stimulation174,175.  
Development of reference databases that resolve the six main leukocyte subtypes to consider 
proportions of subsets with shared lineage but different functionality/phenotype (e.g., naïve vs 
memory vs regulatory subtypes) may allow us to explore this hypothesis and would greatly 
enrich our understanding of immune activity.   
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Our main finding of elevated monocyte proportions in male lifetime PTSD cases is 
consistent with a previous study of Gulf War Illness (GWI) in a predominantly male veteran 
cohort, which reported an association between GWI and increase in monocyte count176.  
However, comparable studies reporting monocyte counts from differential leukocyte count are 
generally lacking; the majority of immune studies of PTSD have focused on inflammatory 
markers (e.g., cytokine levels) and cellular activity, including spontaneous and stimulated 
cytokine production, and studies of cell counts/proportions have focused on lymphocytes, 
particularly T-cell subsets82,84,177-180.  Two PTSD studies that reported monocyte counts based on 
white blood cell differential count found no significant difference in monocyte proportions181,182, 
which is consistent with our results in both sexes, but did not conduct sex-stratified analyses.  
Additionally, a small study in adult females that matched PTSD participants and controls for 
phase of menstrual cycle agreed with our female-specific results and reported no difference 
between PTSD subjects and controls in percentage of any lymphocyte subsets or total numbers 
of leukocytes, neutrophils, lymphocytes, or monocytes183.  PTSD studies investigating peripheral 
lymphocyte numbers have reported mixed findings85,107,178,179,181,184-188, but more recent studies 
that further resolved T-cell subpopulations support PTSD-associated differences in T-cell 
composition indicative of pro-inflammatory skew94,107,188 and immunological aging91.  Many of 
these studies were conducted predominantly in one sex (often in male veteran cohorts107,184-188 
and those based on both sexes did not conduct sex-stratified analyses91,94,181.  To our knowledge, 
no authoritative study of sex differences in complete blood counts in PTSD has yet been 
published, and studies of sex differences in PTSD have generally been lacking, with a number of 
large-scale studies conducted in predominantly male military cohorts (or on female-only cohorts, 
e.g. Nurses’ Health Study II189,190).   
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While not for PTSD, a study of depression that examined white blood cell differential 
count noted a significant increase in monocyte count and proportions among males with major 
depressive disorder (MDD), but not females, and a significant sex by diagnosis interaction191.  
Likewise, a separate longitudinal study following MDD inpatients also reported elevated 
monocyte counts in patients compared to controls, and this was driven by men192.  Additionally, 
a decrease in depression severity was associated with a decrease in monocyte counts192, 
suggesting that monocytes may be related to clinical improvement.  Similarly, the presence and 
severity of atherosclerosis, another condition linked to PTSD via systemic low-grade 
inflammatory state193, are also associated with an increase in monocyte count in males, but not 
females194.  
Further prospective investigation of PTSD is needed to determine whether the higher 
monocyte proportion observed in males reflects an increased susceptibility for developing PTSD 
or if it reflects an immunological shift in response to the precipitating trauma associated with 
PTSD psychopathology.  However, studies in a male rodent model provide strong evidence for 
the latter and have been important for establishing the relationship between peripheral immune 
cells and the brain in the context of psychosocial stress and associated behavior.  Repeated social 
defeat (RSD) was found to induce myelopoiesis and release inflammatory (Ly6Chi) monocytes 
into circulation via sympathetic signaling, and this increased level of circulating peripheral 
monocytes was associated with recruitment of pro-inflammatory monocytes/macrophages to the 
brain and neuroinflammation99,195,196.  Increased proportion of these peripheral monocytes and 
macrophage recruitment to the brain were also demonstrated to correspond with development, 
maintenance, and re-establishment of RSD-induced anxiety-like behavior; blockade of this 
recruitment (via splenectomy or β-adrenergic receptor blockage) before RSD was found to 
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prevent development of anxiety-like behavior101,102.  Additionally, a recent paper discerned that 
stress-induced anxiety-like behavior and social avoidance are dependent on an increase in IL-6 
after stress exposure, which induces a primed transcriptional profile in monocytes recruited to 
the brain and propagates IL-1β mediated inflammation associated with anxiety-like behavior197.  
These studies implicate peripheral monocytes in directly affecting relevant PTSD-like behavior 
after stress exposure in males198,199.  Very recently, the first study using a modified version of the 
RSD paradigm was conducted in female mice and reported a similar onset of anxiety-like and 
social avoidance behavior, increase in myelopoiesis, increase in peripheral monocyte 
proportions, and recruitment of peripheral myeloid cells to the brain, 14 hours after the last RSD 
cycle105.  Continued work based on this paradigm at multiple time points may be fruitful for 
investigating if there are sex differences in the kinetics of leukocyte trafficking and tissue 
distribution, especially since recent investigations in other PTSD-relevant rodent models suggest 
fundamental sex differences in neurobiological response to trauma exposure81 and in regulation 
of stress/trauma-induced neuroinflammatory priming/neuroimmune alterations200,201.  
Furthermore, a social stress paradigm in pregnant rats reported lower numbers of monocytes in 
stressed females than control females rats202, illustrating the importance of considering different 
paradigms and breeds/species.   
Although no studies of PTSD have investigated sex differences in monocyte counts or 
methylomic profiles, chronic PTSD-associated sex differences were noted in transcriptional 
regulation67 and gene expression66 of CD14+ monocytes isolated from peripheral blood.  Given 
the inherent sex differences in innate immune response64,203, as understood in the context of 
infection, injury, and treatment of inflammatory disorders, sexually dimorphic dynamics and 
effects may also exist in the context of neuroimmune response to stress/trauma exposure201.  One 
32 
 
relevant sex difference in monocytes involves the expression of IL-6, which was suggested to be 
important for stress-induced anxiety-like behavior and social avoidance in the RSD model197.  
Independent of reproductive hormones (i.e., estradiol, dehydroepiandrosterone [DHEA], 
progesterone), women were shown to have greater monocyte expression of IL-6 across a 
circadian period than men, and sympathovagal balance was negatively associated with monocyte 
IL-6 expression only in women204.  On the other hand, a study examining sex differences in 
regulation of inflammatory cell recruitment and cytokine synthesis found that ovarian hormones 
regulate phenotype, function, and numbers of macrophages, but not T lymphocytes, in 
females205.  This fundamental sex difference may underlie more efficient recognition and 
elimination of infectious stimuli without recruitment of circulating neutrophils or excessive 
cytokine production in females, compared to males205, and may also have implications in the 
context of psychosocial stress exposure.  Relatedly, statin, which has anti-inflammatory activity, 
modulates monocyte migration in a sex-specific manner, such that both spontaneous and LPS-
induced migration of isolated monocytes were found to be inhibited by statin in women, but not 
men206.   
Our observation of male-specific increase in monocyte proportions associated with 
lifetime PTSD may reflect fundamental sex differences in leukocyte trafficking, tissue 
distribution, and thus composition in blood, with implications for stress/trauma-induced 
neuroimmune alterations and behavior. Of note, while the effect size detected in males translates 
to an absolute difference of only 1.3% in monocyte proportions between participants with vs. 
without PTSD (~8.1% vs. 6.8%; Table 2.3), it also corresponds to an increase of approximately 
19% in overall monocytes among men with lifetime PTSD.  Furthermore, the lack of difference 
between remitted and current PTSD (in male-specific elevation of monocyte proportions) may 
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have a number of implications for PTSD pathophysiology, including adverse health 
consequences associated with PTSD across the life course in men, which may be distinct from 
PTSD-associated health trajectories in women22,207,208.  
Although the current dataset combined two cohorts and known pregnancies were 
excluded from our study, sample size and unavailable phenotype data on pregnancy, timing of 
the menstrual cycle, hormonal birth control use, well-harmonized measures of depression, and 
health status, as well as gender-related variables, such as coping mechanisms, are all limitations 
of this study.  Future studies that account for hormone levels and other fundamental 
physiological sex differences may help identify female-specific associations between PTSD and 
leukocyte composition and clarify if hormone-dependent processes influence leukocyte 
composition dynamics.  Additionally, both cohorts included in this study are civilian, urban, and 
predominantly African-American, so generalizability of our findings may be limited to this 
population.   
Overall, our study implements current state-of-the-art methods to illustrate feasibility of 
using DNAm-based leukocyte composition estimates to probe immune profiles.  Our literature-
supported finding of male-specific elevation in DNAm-based monocyte proportions may be an 
informative metric to include as part of a diagnostic biomarker panel for PTSD in males, and 
future study in females, with consideration for hormonal status, may elucidate a female-specific 
panel as well.  Differential methylation markers discovered in sex-stratified EWAS, which 
account for these cell estimates as covariates, are other prime candidates to be included in such 
sex-specific biomarker panels.  Furthermore, in addition to being able to infer leukocyte 
composition when complete blood count data is not available, these DNAm-based estimates of 
leukocyte composition can be used to determine cell-specific differential methylation profiles.  
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In fact, methods and validation for cell-specific differential methylation analyses have been 
published very recently209,210 and may enable the next significant advance in extracting insights 
from methylomic profiles by contextualizing how differential methylation in specific leukocyte 
subtypes alter regulatory dynamics in the immune system.  Ultimately, this work may help to 
shape future studies designed to determine whether sex-specific methylomic metrics of 
peripheral immune status can inform us about sex differences in neuroinflammation and 
corresponding behavior in response to trauma exposure.   
 
2.6 Conclusion 
By combining DNA methylation datasets from two civilian cohorts, the current study 
found a small but significant elevation in monocyte proportion associated with lifetime PTSD in 
males, but not females.  This sex-specific difference in peripheral blood leukocyte composition 
reflects a long-standing trait of PTSD diagnosis, rather than current state of PTSD.  While this 
finding was confirmed using two different cell estimation approaches (i.e., deconvolution 
algorithms), the recently developed non-constrained projection approach (RPC) appears better 
suited for modeling leukocyte composition.  Methylome-based characterization of immune 
profiles holds special promise for the study of PTSD and continued development of reference 
databases and validation of methods will build on these recent improvements to enrich our 
understanding of sex-specific immune dysregulation associated with PTSD. 
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2.7 Figures and Tables 
 
Figure 2.1: Correlation (Spearman’s rho) between cell estimates derived using robust partial correlation (RPC) and constrained projection (CP) 
deconvolution algorithms is high in all leukocyte subtypes, with CD8+ T cells (CD8T) showing the worst agreement at R = 0.8 in females and R = 
0.87 in males.  CD8T cells also showed the largest discrepancy in sex-specific correlation of estimates.  RPC-CP correlation was > 0.9 and 




Figure 2.2.  Distribution of leukocyte subtypes based on robust partial correlation (RPC) estimates, by sex.  Sex differences in CD8+ T and CD56+ 




Figure 2.3: Violin plots of RPC estimates for lifetime PTSD cases and controls, stratified by sex. Only monocyte proportions in males showed 
statistically significant difference between lifetime PTSD cases and controls, based on Mann-Whitney U test (p-value = 0.004; Holm-adjusted p-
value = 0.026). For figure labels on x-axis: B = CD19+ B cells; NK = CD56+ NK cells; CD4T = CD4+ T cells; CD8T = CD8+ T cells; Gran = 




Figure 2.4: Density plots for RPC monocyte estimates in lifetime PTSD cases and controls, stratified by 
sex, show distinctly higher monocyte levels in males with lifetime PTSD compared to trauma-exposed 
cases.  This difference in monocyte levels between lifetime PTSD case and controls is not observed in 




Figure 2.5: Lifetime PTSD by sex interaction plot for estimated marginal means (EMMs) of RPC 
monocyte estimates.  Interaction plot shows a significant EMM difference between lifetime PTSD cases 
(red) and controls (blue) in males, where mean monocyte estimates are higher in cases than controls.  No 





Figure 2.6: Density plots for RPC monocyte estimates comparing those with current PTSD, remitted 
PTSD, and trauma-exposed controls, stratified by sex.  Distinguishing between current and remitted 
PTSD cases suggests that the significant peak difference in male PTSD cases is associated with long-
standing PTSD trait, rather than current PTSD state.  Corresponding post-hoc Dunn test revealed no 
significant difference between current and remitted PTSD cases and significant differences between 
PTSD case groups and trauma-exposed controls.  Again, no significant differences were observed in 









(n = 330) 
Male 
(n = 153) 
Total 
(n = 483) 
Study 
  DNHS 111 (33.6%) 64 (41.8%) 175 (36.2%) 
  GTP 219 (66.4%) 89 (58.2%) 308 (63.8%) 
Race 
  AA 291 (88.2%) 140 (91.5%) 431 (89.2%) 
  CA 33 (10.0%) 11 (7.2%) 44 (9.1%) 
  Other 6 (1.8%) 2 (1.3%) 8 (1.7%) 
Median Age 
 49.0 (38.0 - 55.0) 48.0 (36.0 - 56.0) 48.0 (37.5 - 55.0) 
Current Smoking 
  no 210 (63.6%) 72 (47.1%) 282 (58.4%) 
  yes 109 (33.0%) 78 (51.0%) 187 (38.7%) 
  Missing 11 (3.3%) 3 (2.0%) 14 (2.9%) 
Lifetime PTSD 
  no 135 (40.9%) 71 (46.4%) 206 (42.7%) 
  yes 195 (59.1%) 82 (53.6%) 277 (57.3%) 
This table describes the subset of participants included in primary analyses investigating sex-specific 
associations between DNAm-based cell estimates and lifetime PTSD, by sex.  For the 2-way ANCOVA, 
14 participants were excluded due to missing current smoking data.   




Table 2.2: Two-way ANCOVA Table for RPC monocyte estimates (n = 469) 
       
Terms 
Type III Sum 
of Squares 
df Mean Square F p partial η
2 
Sex 0.336 1 0.336 1.469 0.226 0.003 
PTSDlife 2.379 1 2.379 10.407 0.001*** 0.022 
Age 2.309 1 2.309 10.101 0.002*** 0.021 
ancPC1 0.000 1 0.000 0.001 0.977 0.000 
ancPC2 0.219 1 0.219 0.957 0.329 0.002 
Smoking 0.060 1 0.060 0.261 0.610 0.001 
Sex:PTSDlife 1.146 1 1.146 5.011 0.026* 0.011 
Residuals 105.399 461 0.229 
   
















Table 2.3: Summary for RPC monocyte estimates by group 
Sex PTSD n mean SE EMM SEEMM lower.CL upper.CL 
Female no 135 7.113 0.2443 6.758 0.2214 6.330 7.200 
Female yes 184 7.182 0.1691 7.014 0.1893 6.647 7.391 
Male no 70 6.803 0.3228 6.507 0.2926 5.945 7.095 
Male yes 80 8.103 0.3147 7.921 0.3063 7.331 8.535 
 
This table describes untransformed RPC monocyte estimates by group (i.e., sex and lifetime PTSD); 
n = count per group; EMM = estimated marginal means (i.e., least squares means); SE = standard errors 
for regular means; SEEMM = standard errors for EMM. 
 
Lower and upper confidence limits are for 95% level.  EMM and intervals were back-transformed from 
the square root scale to the original scale of cell subtype proportions (%).  Significance level of alpha = 
0.05 was used for EMM comparisons.  Results for pairwise comparison were averaged over levels for 
current smoking.  Degree of freedom was 461 and male lifetime PTSD cases were significantly different 
from other groups. 
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CHAPTER 3: SEX-SPECIFIC AND SHARED EXPRESSION PROFILES OF 
VULNERABILITY AND RESILIENCE TO TRAUMA IN BRAIN AND BLOOD 
 
3.1 Abstract 
While post-traumatic stress disorder (PTSD) is defined by behavioral/cognitive 
symptoms most directly relevant to brain function, it can be considered a systemic disorder 
characterized by a distinct inability to reinstate homeostasis after trauma.  In this study, we 
investigated expression profiles of key PTSD-relevant tissues, namely blood, amygdala, and 
hippocampus, from a rat model of PTSD, to identify sex-specific and shared processes associated 
with individual differences in response to recent trauma exposure.  Our findings suggest both 
shared and sex-specific mechanisms underlying individual differences associated with 
vulnerability and resilience to trauma in hippocampus, amygdala, and blood.  By disentangling 
cell composition from transcriptional changes, we found higher proportions of hippocampal 
oligodendrocytes in the PTSD-like, extreme behavioral response (EBR) group for both sexes and 
also identified modules for transcriptional activity associated with group differences (ie., 
response to trauma) in the hippocampus that appeared to be sex-specific.  By contrast, we found 
prominent sex differences, but no group differences, in amygdalar cell composition, and both 
shared and sex-specific modules representing PTSD-relevant transcriptional activity in the 
amygdala.  Across amygdala and hippocampus, both sex-specific and shared processes were 
relevant to an overarching framework for EBR implicating disrupted TNFα/NFκΒ signaling and 
excitatory/inhibitory imbalance in dysregulated synaptic/structural plasticity with important 
implications for fear learning and memory.  Our main finding in peripheral blood was consistent 
with the human literature and identified wound healing processes and hemostasis to be 
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upregulated in the resilient, minimal behavioral response (MBR) group across sexes, but 
disrupted in a sexually dimorphic manner in the EBR group.  Unlike the varied characterization 
of the EBR group, characterization of MBR across blood, amygdala, and hippocampus suggests 
a common theme of upregulated wound healing and extracellular matrix (ECM) remodeling 
shared between sexes.  In all, we identified differential oligodendrocyte proportions in 
hippocampus between PTSD-like EBR and resilient MBR, and identified processes and 
pathways that characterize the EBR and MBR-associated transcriptional changes across 
hippocampus, amygdala, and blood.  The sex-specific mechanisms involved in EBR may 
contribute to the pronounced disparity in risk for PTSD, with women much more likely to 
develop PTSD.   
 
3.2 Introduction 
Identifying robust peripheral biomarkers that can be used for implementing early 
intervention and developing improved preventative or therapeutic strategies would be valuable 
for managing post-traumatic stress disorder (PTSD), especially since accessing human brain 
tissue is often not a viable option.  This requires understanding the relationship between brain 
and peripheral tissue, such as blood, in the context of stress/trauma exposure.  Evidence from the 
past decade has demonstrated a key role for immune dysregulation in PTSD211,212.  In fact, while 
PTSD is defined by behavioral/cognitive symptoms most directly associated with brain function, 
it can be considered a systemic disorder involving physiological changes throughout the body 
across all stages of PTSD213.  PTSD symptoms reflect a distinct inability to reinstate homeostasis 
after trauma, and they involve bidirectional crosstalk between the brain and the rest of the body, 
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prominently via peripheral blood, which serves as a conduit for neuroendocrine and immune 
signaling.   
Notably, systemic inflammation may underlie the pathophysiology of PTSD, as well as 
the consistent link between PTSD and chronic medical conditions associated with aging, such as 
cardiovascular, metabolic, autoimmune, and neurodegenerative diseases190,207,214-216, and other 
markers of accelerated aging91,123,215-220.  This dysregulated inflammatory state is itself partially 
coordinated by maladaptive alterations of hypothalamic-pituitary adrenal (HPA) axis activity and 
sympathetic nervous system (SNS) sensitivity/responsivity221,222, which affect both peripheral 
immune cells in blood and neuroimmune dynamics in brain.  Since these systemic regulatory 
processes coordinate both brain and blood, ultimately, we would like to determine if 
transcriptomic signatures of peripheral immune status can inform us about neuroinflammation in 
the brain and corresponding behavior in response to stress.  Furthermore, while not extensively 
studied in the context of stress and psychoneuroimmunology, these regulatory systems, involved 
in stress and immune response, are known to have prominent sex differences64,65,203.  Thus, 
considering sex-specific mechanisms in cross tissue investigations is warranted for 
characterizing the alterations in peripheral and central nervous system immune states (e.g., 
neuroinflammation), in response to disrupted HPA, SNS, and immune signaling.   
Gene expression (GE) profiles serve as a useful biological readout; taking GE 
“snapshots” across peripheral blood and key brain regions can help identify processes and 
pathways disrupted in PTSD that are shared across different tissues, particularly between easily 
accessible peripheral blood and brain.  Animal models of PTSD are key resources that provide 
access to both blood and brain tissues and allow control of stress/trauma exposure.  In this study, 
we draw from a publicly available dataset223 that models PTSD using a cut-off behavioral 
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criteria, to assign outbred rats as “vulnerable” or “resilient” based on their behavioral response 
after stress/trauma exposure (i.e., predator scent stress)44,224.  This model is able to differentiate 
individual behavioral response to stress from general stress response by grouping two extremes 
of behavior using “diagnostic” inclusion-exclusion criteria, to capture PTSD-like 
(avoidance/hyperarousal) and resilient/resistant225 phenotypes as groups distinct from the general 
population (i.e., middle 50%, not included)226.  By also including unexposed controls, we are 
able to distinguish: 1) differential response to stress exposure (vulnerable vs. resilient), which is 
analogous to human studies of PTSD cases and trauma-exposed controls; 2) individual response 
to stress exposure (vulnerable exposed vs. unexposed or resilient exposed vs. unexposed); and 3) 
general response to trauma exposure (exposed [vulnerable and resilient] vs. unexposed).   
Here, we examine expression profiles of blood, amygdala, and hippocampus from this rat 
model of PTSD223,226, to identify sex-specific and shared pathways associated with group 
differences in response to recent trauma exposure, in each of these key PTSD-relevant tissues.  
In addition to capitalizing on the strengths of this animal model, we disentangle transcriptional 
activity from cell composition (and/or other covariates) in the bulk expression profile and assess 
the contributions of cell composition and transcriptional activity to group differences in each 
tissue.  In order to gain a systems-level understanding of transcriptional activity occurring in 
each tissue, we implement an unsupervised co-expression network approach – to identify groups 
of genes within a network (i.e., gene modules) and explore their association with sex-stratified 







Non-normalized microarray datasets, deposited by the Daskalakis et al. (2014)223 study, 
were obtained from the NCBI GEO database227.  They consisted of 47 blood (GSE60280; 8 
samples per group per sex, with one sample missing), 30 amygdalar (GSE60302; 5 samples per 
group per sex), and 30 hippocampal (GSE60303; 5 samples per group per sex) samples derived 
from a rat model of PTSD (detailed below) and acquired using the Illumina RatRef-12 v1.0 
Expression BeadChip Array platform.  Details regarding the dataset and sample processing 
protocols are published in the original paper223.  All data import, processing and analyses were 
conducted in R (version 3.5.1)151.    
 
Animal Model of PTSD 
The animal model of the PTSD used in Daskalakis et al. (2014)223 was developed by 
Cohen and Zohar226 and involved brief exposure (10 min) of adult outbred Sprague-Dawley rats 
to predator-scent stress (PSS), an ecologically valid stressor that mimics a life-threatening 
situation for rodents.  Seven days after PSS exposure, the animals were tested for behavioral and 
physiological response to provocation, and those at either end of the response distribution were 
categorized as being either vulnerable (EBR; extreme behavioral response) or resilient (MBR; 
minimal behavioral response), based on statistically validated cut-off behavioral criteria 
(CBC)224.  The elevated plus-maze (EPM) and acoustic-startle response (ASR) behavioral tests 
were used to assess anxiety and arousal, respectively.  Comparisons of expression profiles were 




Quality Control and Data Processing  
Minimal probe detection and inter-array correlation (IAC; Pearson’s) were assessed to 
identify sample outliers.  One blood and one hippocampus sample were excluded due to low 
signal (less than 4000 significantly detected probes at detection p-val < 0.01).  Then, one sample 
outlier was identified and removed for each tissue dataset, based on low mean IAC calculated for 
all pairs of samples within each tissue dataset (standard deviations from mean IAC < -2.5).  After 
sample removal, 45 out of 47 blood samples, 28 out 30 hippocampal samples and 29 out of 30 
amygdalar samples were retained.  Table 3.1 presents the breakdown of samples used in analyses 
by tissue, group and sex.   
Expression datasets for each tissue were normexp background-corrected, quantile 
normalized, and log2 transformed, separately using neqc in the limma package
228,229.  For 
background correction, observed intensities were fit to a normal+exponential convolution model, 
estimating model parameters using detection p-value to infer mean and variance of negative 
control probes.  Probes were filtered for low expression in each tissue dataset and annotation 
quality (out of 22,523 total probes).  Retained probes had a detection p-value < 0.01 in at least 
10% of subjects, consistent chromosome mapping between annotation sources, and mapping to 
human orthologs.  For 1:1 gene:probe mapping, genes mapped to multiple probes were 
represented by the probe with highest mean expression levels across samples in each tissue 
dataset.  After data processing, each tissue dataset retained 4,901 expressed genes (represented 
by 5,065 probes) in blood, 6,653 genes (represented by 6,869 probes) in hippocampus, and 6,811 






Probe annotations were based on platform, organism, and transcriptome level annotations 
packaged in Bioconductor (version 3.7)153,154 databases.   Re-annotated gene symbols (based on 
re-mapping of Illumina Rat v1 probe sequences with ReMOAT230; illuminaRatv1.db) were used 
to retrieve updated NCBI Entrez Gene IDs (April 2018; org.Rn.eg.db).  Entrez Gene IDs were 
used to map genes to UCSC rn5 genome coordinates (TxDb.Rnorvegicus.UCSC.rn5.refGene; 
April 2018) and predicted human orthologs in the Molecular Signatures Database (MSigDB 
v6.2.1, released July 2018; msigdbr).  For multi-mapping genes, human ortholog is chosen 
within MSigDB based on support by the largest number of databases (eggNOG, Ensembl 
Compara, HGNC, HomoloGene, Inparanoid, NCBI Gene Orthology, OMA, OrthoDB, 
OrthoMCL, Panther, PhylomeDB, TreeFam and ZFIN). 
 
Brain Cell Proportion and Surrogate Variable Estimation  
Since no validated reference datasets were available for peripheral blood and brain cell 
types in rats, cell estimation was attempted using marker sets constructed in other species.  Brain 
cell subtypes were estimated using the BRETIGEA package, which includes well-conserved 
consensus brain cell marker sets identified across mouse and human datasets231 and implements a 
singular value decomposition approach (SVD), based on CellCODE232.  This marker set from 
combined human and mouse measurements contains 1000 markers each for six brain cell types: 
astrocytes (ast), endothelial cells (end), microglia (mic), neurons (neu), oligodendrocytes (oli), 
and oligodendrocyte progenitor cells (opc).  Of these, only markers expressed in each brain 
dataset were used for cell estimation (Table 3.2).   
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Leukocyte cell estimation was attempted using a recently published mouse reference 
signature matrix, consisting of 511 distinguishing genes for 25 immune cell types233, modeled 
after the human LM22 signature matrix constructed for use with the CIBERSORT234 
deconvolution approach.  However, this reference dataset was inadequate for deriving reliable 
leukocyte cell estimates: only 142 out of the 511 signature genes were expressed in our blood 
dataset.  Comparison between mouse and rat genomes have previously revealed significant 
genomic differences in immune system-related genes between the two rodent models235.  
Notably, rats have higher evolutionary rates for these genes and thus possess immune-related 
genes not found in mouse235.  Thus, cell estimates were only calculated for brain tissues (i.e., 
hippocampus and amygdala).  
In addition to estimation of brain cell proportions, we conducted surrogate variable 
analysis236 on processed expression datasets to derive surrogate variables (SVs) for each tissue, 
while accounting for sex-stratified group, defined as each individual response category by sex 
(six levels, e.g.., female EBR, male MBR, female CON).  There were 4 SVs identified in 
hippocampus, 5 SVs identified in amygdala, and 9 SVs identified in blood.  Computed SVs were 
used to account for expression heterogeneity associated with technical and biological artefacts, 
and are assumed to proxy contributions of cell composition to expression heterogeneity (among 
other latent sources of confounding)237.   
 
Cell Composition Analysis in Brain Tissue 
Shapiro-Wilk test was used to assess normality and Levene’s test (using median as 
center; modified Brown-Forsythe) was used to compare equality of variance among groups.  
Since not all cell subtype estimates had normal distributions (by population), Mann-Whitney U 
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test was used to compare mean ranks of cell estimates for initial comparisons by trauma-exposed 
group (EBR vs MBR) and sex, across cell subtypes, when equality of variance was met.  Two-
sample Kolmogorov-Smirov (KS) test was used to compare distribution of non-normal cell 
estimates when variances were unequal between groups.  For cell subtypes of interest that met 
modeling assumptions, one-way analysis of covariance (ANCOVA) was used to test main effect 
of each variable (EBR vs MBR).  Kruskal-Wallis and post-hoc Dunn tests were used for group 
comparisons including trauma un-exposed controls.  A threshold of 0.05 was used for p-values 
and p-values were adjusted for multiple comparisons using Holm’s method170 in cell composition 
analyses.   
 
Differential Expression and Gene Set Enrichment Analyses in Blood 
 Since we were not able to estimate cell proportions in blood and had more samples in the 
blood dataset than in datasets from brain tissues, we conducted differential expression analyses 
in blood, to cross-check with network analyses.  Association between group and gene expression 
due to transcriptional changes was assessed by fitting a linear regression model of gene 
expression as a function of sex-stratified group while accounting for SVs as covariates in the 
model.  Sex-stratified contrasts were applied to the model fit to investigate EBR vs. MBR, EBR 
vs. CON, and MBR vs. CON differences.  The linear model and sex-stratified contrasts were 
fitted using an empirical Bayes approach in limma to compute moderated t-statistics and log2 
fold change (logFC)228,238 for each probe in each comparison, to determine differential expression 
(DE) for each sex-stratified comparison (FDR-adjusted p-value < 0.05).   
Pre-ranked gene set enrichment analysis (GSEA)239 was conducted for each sex-stratified 
comparison using a sorted vector of logFC as input.  The fgsea algorithm for fast gene set 
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enrichment analysis240 was implemented via clusterProfiler241 for gene sets in the hallmark gene 
set collection from the Molecular Signatures Database (MSigDB v6.2, released July 2018)239,242 
that had a minimum of 10 and maximum of 500 genes.  The p-value of the enrichment score 
(representing the degree to which a gene set is over-represented at the top or bottom of the 
ranked logFC list) was calculated by permutation test (1000 permutations) and adjusted for 
multiple hypothesis testing using the Benjamini-Hochberg (BH) method243 (adj p < 0.05).   
 
Gene Co-expression Network Analysis 
 Signed co-expression gene network construction and gene module discovery were 
conducted using the CEMiTool package244, which implements a novel soft threshold (β) selection 
algorithm, distinct from the original weighted gene co-expression network analysis (WGCNA) 
approach245.  The β power parameter selection was conducted after variance-based filtering of 
expression data, using default settings.  For construction of signed co-expression networks, the 
weighted network adjacency matrix was calculated by raising the co-expression similarity 
measure to the selected β, and biweight midcorrelation (bicor) was used as the co-expression 
measure, unless otherwise noted.  For module detection, genes were assigned to modules using 
the dynamic tree cutting method246 on branches of the hierarchical clustering dendrogram of the 
signed topological overlap dissimilarity matrix (1-TOM).  Modules with eigengene correlations 
> 0.8 were merged and minimum module size was set to 30 genes.  Group differences for 
activity of identified gene modules (i.e., upregulation or downregulation; induced/repressed) 
were determined via CEMiTool using the fgsea  algorithm240, treating genes in co-expressed 
modules as gene sets and the z-score normalized expression of samples within each group as 
rankings on the analysis.  Unsupervised network analyses in brain tissues were conducted on 
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both SV and cell proportion-adjusted expression data, while analyses in blood were conducted on 
SV-adjusted data only.  Network analyses were also conducted on unadjusted expression data for 
all tissues for comparison, to infer whether modules represented general processes independent 
of cell proportions or if they may be linked to cell proportions and other covariates.   
Gene set analyses were conducted for MSigDB v6.2 gene set collections (not including 
cancer-specific collections)239,242 using hypergeometric testing (over-representation analysis) as 
implemented in clusterProfiler241, for modules of interest identified in gene co-expression 
network analyses (adj p < 0.05; BH p-val adjustment; gene set with 10-500 genes; qval cutoff 
0.2).  To identify potential hubs, module graphs were constructed for protein-protein interactions 
(PPI) from the human PPI dataset on BioGRID247,248.  Appendix B contains all gene co-
expression network analysis and gene set analysis results, including CEMiTool reports for all 
analyses with modules detected and tabulated results for gene set analyses of all MSigDB 
collections with significant results.   
 
3.4 Results 
Higher proportions of hippocampal oligodendrocytes observed in EBR compared to MBR and 
CON groups, in both sexes 
Non-parametric Mann-Whitney U test revealed higher median proportions of 
hippocampal oligodendrocytes in the extreme behavioral response (EBR; PTSD-like) group 
compared to the minimal behavioral response (MBR; resilient) group in both sexes, Z = -2.78, 
Holm-adj p = 0.024, r = 0.66 (Figure 3.1).  ANCOVA testing the effects of group and sex 
confirmed significant group differences (EBR vs MBR), F(1,15) = 11.4, p = 0.004, and no 
significant sex differences, F(1,15) = 0.05, p = 0.82, in oligodendrocyte proportions (Table 3.3).  
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A small, yet significant, difference in hippocampal oligodendrocyte proportions was also 
observed between EBR and trauma-unexposed control (CON) groups by Kruskal-Wallis, H(2) = 
9.3, p = 0.01, and post-hoc Dunn test (Table 3.4).   No significant difference was observed 
between MBR and CON groups.   
Additionally, unsupervised network analysis of hippocampal expression levels before cell 
subtype adjustment identified a gene module significantly associated with upregulation in EBR 
and downregulation in MBR groups of both sexes, as well as downregulation in the female CON 
group (M2: 104 genes; Figure 3.2A).  While the module was not significantly enriched for GO 
terms, in the curated chemical and genetic perturbation gene set collection (C2 CGP) from the 
MSigDB database, the top hit enriched in this EBR – MBR module was for oligodendrocyte 
markers (adj p = 0.009; 7 out of 45 genes in LEIN_OLIGODENDROCYTE_MARKERS).  
Comparison of modules from network analyses before and after cell subtype adjustment 
confirmed the module enriched for oligodendrocyte markers was lost after adjustment, 
suggesting the enrichment was related to hippocampal cell proportions.  Together, results from 
cell composition and unsupervised network analyses suggest that an increase in hippocampal 
oligodendrocyte proportions occur in the PTSD-like EBR group, but not the resilient MBR 
group, in response to trauma exposure.  Group differences were not detected in any other 
hippocampal cell subtype.   
 
PTSD-relevant hippocampal gene expression modules are sex-specific 
 Network analyses conducted on the full (both sexes), cell-adjusted hippocampal 
expression data identified a module associated with upregulation in the female EBR group, 
weaker upregulation in the male MBR group and downregulation in the unexposed CON group 
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from both sexes (M1: 165 genes; Figure 3.2B).  Top GO terms enriched in this module were 
cellular response to endogenous stimulus, response to organic cyclic compound, and response to 
lipid.  Relatedly, top hits from other gene set collections identified enrichment for genes up-
regulated after stimulation with NRG1 and EGF in the C2 CGP collection and TNFα signaling 
via NFκB pathway in the MSigDB Hallmark collection, implicating activation of ligand-receptor 
signaling as one possible mechanism for significant processes identified among GO terms.  
While there were no other modules based on adjusted hippocampal data to confirm the MBR – 
CON comparison in males, the EBR – CON comparison in females was confirmed in modules 
identified from SV-adjusted hippocampal data (female subset and full set).  The EBR – CON 
module identified from the female subset of SV-adjusted hippocampal data (M2: 144 genes; 
Figure 3.3A) was significantly enriched for all the top gene sets identified with the M1 module 
from cell-adjusted hippocampal data (Table 3.5) and the female EBR – CON module based on 
the full SV-adjusted dataset (M1: 81 genes; Figure 3.2C) was significantly enriched for the top 
hallmark and C2 CGP terms, but not GO terms.  Of note, the gene set for genes upregulated after 
NRG1 stimulation was identified as the top hit in the C2 CGP collection in all three EBR – CON 
modules and module gene members (i.e., genes in the module that overlap with genes in gene 
set) in the EGF signaling gene set were a subset of module gene members in the NRG1 signaling 
gene set.  Thus, while both gene sets were top hits, upregulation by NRG1 signaling is endorsed 
over EGF signaling in our results.  In summary, analyses of both cell and SV-adjusted 
hippocampal data provided consistent evidence implicating upregulation of genes after NRG1 
stimulation, and TNFα signaling via NFKΒ pathway in the female EBR group, but not in the 
male EBR group; in fact, the M1 module based on full, cell-adjusted data suggests that enriched 
processes are associated with the MBR group in males.   
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 Sex-stratified network analyses on SV-adjusted data detected a second module in the 
female subset, which was associated with upregulation in MBR and downregulation in the EBR 
group (M1: 170 genes; Figure 3.3B).  This female-specific MBR – EBR module was 
significantly enriched for neurological system process, proteinaceous extracellular matrix 
(ECM), extracellular structure organization, ensheathment of neurons, and long-term synaptic 
potentiation among GO terms (Figure 3.4).  ECM relevant terms were corroborated by 
significant enrichment for ECM receptor interaction among KEGG pathway gene sets (adj p = 
0.009, 6/31genes).  Interestingly, the top hit in the C2 CGP collection was for genes with high-
CpG density promoters (HCP) bearing histone H3K4me3 and H3K27me3 in brain (adj p = 
0.0012, 28/387 genes; MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3).  In 
embryonic stem cells, genes containing HCPs enriched with both H3K4me3 and H3K27me3 
histone marks (associated with transcription initiation and repression, respectively) were found to 
be highly regulated developmental genes249, and this histone state is itself dynamic and 
correlated with DNA methylation levels250.  Thus, enrichment for this gene set suggests the 
module is dynamically regulated by this epigenetic mechanism.   
 Network analyses on the male subset of SV-adjusted hippocampal expression data most 
notably identified one module associated with upregulation in the EBR group (M2: 101 genes; 
NES 1.75; Figure 3.3C).  This EBR-related module was significantly enriched for regulation of 
GABAergic synaptic transmission, the TCR pathway, G alpha I signaling events, G-protein 
coupled receptor (GPCR) signaling, and transcription factor targets (TFTs) for GR, CEBP, and 




Prominent sex differences in amygdalar cell composition is accompanied by both shared and 
sex-specific PTSD-relevant expression modules  
 While no significant group differences were detected for any cell subtype in the 
amygdala (Holm-adj p < 0.05), prominent sex differences were observed in the distribution of 
cell subtype proportions, based on Levene’s and Kolmogorov-Smirnov tests (Table 3.7).  
Females, regardless of group, showed significantly greater variance in distribution of relative cell 
proportions for astrocytes (ast), neurons (neu), oligodendrocytes (oli), and oligodendrocyte 
progenitor cells (opc), compared to males (Figure 3.5).    
 Network analysis of amygdalar expression levels after cell subtype adjustment identified 
three modules putatively associated with group, either shared between sexes or sex-specific 
(Figure 3.6).  Module M2 (59 genes) was associated with upregulation of MBR compared to 
CON in both sexes, and was enriched for GO terms related to extracellular matrix (ECM), 
including collagen fibril organization (Figure 3.7A), which were corroborated by significant 
enrichment to matrisome-related terms in the C2 CP collection and ECM organization among 
REACTOME pathways.  Module M3 (55 genes) was weakly associated with downregulation in 
EBR groups of both sexes and upregulation in the female MBR group.  The top GO terms 
enriched in this module were for GPCR signaling pathway, synaptic signaling and 
somatodendritic compartment (Figure 3.7B).  Enrichment results in the REACTOME pathway 
collection corroborated significant GO hits and suggested enrichment for regulation of insulin 
secretion by glucagon-like peptide1 and GABAβ receptor activation (Figure 3.8A).  In all, cell-
adjusted network analyses suggest significant upregulation of processes involved in ECM 
organization in the MBR relative to unexposed CON, and downregulation of GPCR and synaptic 
signaling in the EBR group in the amygdala, which is shared by both sexes.  However, we note 
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downregulation of these pathways/processes in EBR is differentiated from the MBR group only 
in females.   
Sex-stratified network analyses on cell-adjusted amygdalar expression levels did not 
identify any notable PTSD-relevant module in the male subset but identified one module in the 
female subset associated with upregulation in the MBR group and downregulation in the EBR 
group (M2: 40 genes).  Top GO terms enriched in this module were GPCR signaling pathway, 
neurological system process, and behavior (Figure 3.8B); these top GO hits were corroborated by 
significantly enriched terms among REACTOME gene sets.  Additionally, the module was 
enriched for BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 (C2 CGP; adj p = 0.0003; 
13/422 genes).   
Network analyses based on the full SV-adjusted dataset did not identify any notable 
PTSD-relevant modules, but sex-stratified network analyses on SV-adjusted data identified one 
large module, using Spearman correlation as the co-expression measure, in the male amygdalar 
subset and three modules in the female subset (Figure 3.9).  In females, module M3 (108 genes), 
associated with downregulation in EBR and upregulation in MBR, was significantly enriched for 
GO terms related to TF activity (RNAPII core promoter, proximal region sequence-specific 
binding), particularly for transcriptional activator activity, and muscle tissue/structure 
development.  Analyses in other gene set collections identified top enrichment for TNFα 
signaling via NFκΒ (adj p = 1.5e-08, Hallmark), four gene sets associated with the SRF 
transcription factor (C3 TFT), and genes downregulated in neurons after NPAS4 knockdown by 
RNAi (adj p = 1.34e-06).   
In males, the identified PTSD-relevant module was associated with downregulation in the 
EBR and relative upregulation in the CON group (M1: 453 genes).  The top GO term enriched in 
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this module was GPCR signaling pathway, which was corroborated by significant terms from the 
REACTOME gene set collection and agreed with the top GO term associated with module M3 
from cell-adjusted amygdalar data, suggesting this pathway may be generally downregulated in 
the EBR group from both sexes.  Other GO terms significantly enriched in this male M1 module 
were response to organic cyclic compound/lipid/(steroid) hormone/nitrogen compound.  The 
module was also significantly enriched for neuroactive ligand receptor interaction (KEGG, adj p 
= 0.016), TNFα signaling via NFκΒ (Hallmark, adj p = 0.002), hypoxia (Hallmark, adj p = 0.03), 
and MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 (C2 CGP, top hit, adj p = 
5.06e-09).   
 
Wound-healing processes in blood are upregulated in MBR across sexes, but sexually dimorphic 
in EBR 
While no modules were identified on the full SV-adjusted data, sex-stratified network 
analyses of SV-adjusted blood expression levels (Figure 3.10A,B) identified a module 
upregulated in the MBR group compared to the unexposed CON group in both males (M1: 134 
genes) and females (M1: 186 genes).  In both sexes, the module was significantly enriched for 
GO terms relevant to wound healing, such as platelet activation, response to wound healing, and 
hemostasis, as well as regulation of body fluid levels (Figure 3.11), and these terms were 
corroborated in other gene set collections for platelet-specific genes (C2 CGP, top hit in both), 
hemostasis (REACTOME).  Interaction networks constructed from sex-stratified SV-adjusted 
blood expression levels identified FOS, ALOX12, PCMT1, YWHAH, and SSX2IP as common hub 
genes in both male and female subsets (Figure 3.12).   
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Sex-specific enrichment was also observed in this MBR – CON module.  In males, the 
module was significantly enriched for GPCR signaling pathway and this was corroborated by 
significant hits from the REACTOME gene set collection.  Additionally, the top hit among 
KEGG pathways was vascular smooth muscle contraction, which had 7 out of 39 genes in 
common with the male MBR – CON module.  Of these, PPP1CC was identified as a significant 
interaction hub gene in the module’s interaction network (Figure 3.12A) and was notably found 
to be differentially expressed between MBR and CON groups in males, but not in females.  
Furthermore, this gene was not included in the female MBR – CON module, suggesting 
PPP1CC may be a key gene overexpressed in the male MBR group and relevant to male-specific 
differences in individual response to trauma.   
In females, the MBR – CON module was enriched for biological adhesion and 
extracellular space and significant hits among REACTOME pathways corroborated GO terms, 
involving cell junction organization, cell-cell communication, and hemostasis.  This module was 
also enriched for the complement pathway in the hallmark collection and for TFTs of MEF2, 
HNF1, and SRF, implicating these transcription factors in putatively coordinating MBR-
associated upregulation in females.   
No modules were detected before SV adjustment in males, but the MBR – CON module 
was identified in unadjusted blood expression levels for both the female subset (M1: 157 genes; 
Figure 3.10C) and full set (M2: 89 genes; Figure 3.10D).  In fact, the modules based on 
unadjusted data were more significantly enriched for shared GO terms and other top hits.  This 
indicates that MBR upregulation of wound healing processes, particularly involving 
hemostasis/platelets, and regulation of body fluid levels are independent of MBR associations 
with other covariates, which were modeled as 9 SVs in blood.  We also observed this module 
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was more strongly enriched in females (MBR.F: NES = 3.7; CON.F: NES = -3.44) than in males 
(MBR.M: NES = 1.66; CON.M: NES = -2.2).   
Interestingly, while upregulation in the MBR group is shared between sexes, the M2 
module based on the full unadjusted blood expression data shows sex differences in the EBR 
group, such that female EBR is upregulated while male EBR is downregulated for this wound 
process-related module (Figure 3.10D).  In fact, the downregulation in the male EBR group has a 
greater effect than the male control group (EBR.M: NES = -2.64; CON.M: NES = -2.2).  This 
suggests there may be a sex-specific EBR response to stress/trauma for the processes represented 
in this module.  As this sexually dimorphic association is observed only in this module on the 
full, unadjusted data and not detected in sex-stratified SV-adjusted modules, enrichment terms 
unique to this module may be most relevant for these sexually dimorphic EBR effects.  The 
reactive oxygen species (ROS) pathway was identified as a top hit only in the full, unadjusted 
M2 module, implicating response to ROS/oxidative stress as a high priority pathway for sex 
differences in the EBR group. 
In addition to these MBR-related findings, a module associated with downregulation in 
EBR and relative upregulation in unexposed CON group was identified in females (M2: 112 
genes; Figure 3.10B).  This female-specific CON – EBR module was significantly enriched for 
GO terms related to immune and defense response, as well as coagulation, IL6-JAK-STAT3 
signaling, and interferon gamma response in the hallmark gene set collection.  These hallmark 
processes were also significantly associated with female EBR vs. MBR and EBR vs. CON 
contrasts in gene set enrichment analyses of differential expression results (Appendix B).  
Notably, interferon gamma (IFNγ) response was the top hit in gene set enrichment analyses of 
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both the female EBR vs. MBR and EBR vs. CON comparisons, suggesting IFNγ may be a key 
player involved in PTSD-like response to trauma in females.   
 
3.5 Discussion 
In this study, we investigated expression profiles of key PTSD-relevant tissues, namely 
blood, amygdala, and hippocampus, from a rat model of PTSD, to identify sex-specific and 
shared processes associated with individual differences in response to recent trauma exposure.  
By estimating cell proportions from brain expression profiles, we found higher proportions of 
hippocampal oligodendrocytes in the PTSD-like EBR group compared to the resilient MBR and 
unexposed CON group in both sexes, and this was supported by enrichment for oligodendrocyte 
markers in network analyses on unadjusted hippocampal data.  While no group-related 
differences in cell proportions were detected in the amygdala, prominent sex differences were 
noted, with females showing significantly greater variance in distribution of relative cell 
proportions for astrocytes, neurons, oligodendrocytes, and oligodendrocyte progenitor cells.  Cell 
proportion estimates and surrogate variables (SVs) were also used for data adjustment in network 
analyses to identify gene modules reflecting transcriptional activity, rather than coordinated 
expression reflecting a mix of cellular composition and transcriptional activity.  By accounting 
for cell proportions and surrogate variables (SVs), we were able to identify a number of shared 
and sex-specific gene expression modules reflecting group differences in transcriptional activity, 





Our finding of higher hippocampal oligodendrocyte proportions in the EBR group is 
consistent with reports from a recent study that used a metric based on magnetic resonance 
imaging (MRI) to estimate hippocampal myelination in male veterans with and without PTSD 
(due to combat trauma)251; veterans with PTSD had significantly more hippocampal myelin than 
trauma-exposed controls, and there was a positive correlation between hippocampal myelination 
estimates and PTSD symptom severity251.  Relatedly, in rats, immobilization stress and 
corticosterone have been demonstrated to induce oligodendrogenesis in the dentate gyrus (DG) 
of adult hippocampus252, suggesting stress induces hippocampal myelin formation.  In our study, 
post-hoc Dunn test for hippocampal oligodendrocytes showed a stronger effect size in the EBR 
vs. MBR comparison than the EBR vs. CON comparison and no significant difference between 
the MBR and CON groups, suggesting that differences in hippocampal oligodendrocyte 
proportions reflect PTSD-relevant differences in response to trauma (consistent with the study in 
humans) rather than differences due to trauma exposure (consistent with the study in rats).  
Diffusion tensor imaging studies have endorsed significant alterations in white matter (WM) 
integrity, as measured by fractional anisotropy (FA), which are associated with trauma exposure, 
current PTSD diagnosis, current and lifetime PTSD symptom scores, PTSD status (e.g., remitted 
vs. persistent), and treatment outcome253-256.  Both decrease253,256 and increase254,255 in FA were 
reported in different brain regions/tracts and contexts, with WM changes suggested to change 
over the course of PTSD.  Moreover, investigation in oligodendrocyte precursor cell (OPC) 
culture demonstrated an interplay between pro-inflammatory cytokines and corticosteroids, such 
that IFNγ and TNFα impair survival and maturation of OPCs and co-administration of 
corticosteroids, most prominently dexamethasone, counters these deleterious effects257.  Taken 
together, these studies support a model where dynamic, brain region-specific changes in white 
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matter associated with stress/trauma exposure and PTSD pathophysiology reflect stress and 
neuroinflammation-dependent remodeling at the cellular/molecular level via dynamics in 
myelination and OPC survival, proliferation, and differentiation/maturation.   
Findings from our hippocampal network analyses endorse group differences in 
transcriptional activity that fit into the framework of this model and the broader PTSD literature 
on hippocampus that have consistently endorsed diminished neuronal and functional integrity 258.  
Furthermore, our results suggest that there may be sex differences.  Among the modules 
identified across hippocampal network analyses (i.e., full dataset vs. sex-stratified, SV-adjusted 
vs. cell estimate-adjusted), we highlight a module associated with upregulation in the EBR group 
in each sex and one notable module significantly associated with upregulation in MBR and 
downregulation in EBR that was detected only in females.   
 First, the female-specific MBR – EBR module was significantly enriched for 
extracellular structure organization, ECM receptor interaction, long-term synaptic potentiation, 
ensheathment of neurons, neurological system processes, and gliogenesis.  When taken together, 
these enrichment results endorse group differences in the ECM and associated signaling, which 
may be related to glial regulation of hippocampal synaptic plasticity, specifically long-term 
synaptic potentiation which has implications for learning and memory, via ensheathment of 
neurons.  As oligodendrocyte proportions were found to be higher in the EBR than the MBR 
group, enrichment for gliogenesis and ensheathment of neurons may potentially reflect 
involvement of other glial cells, such as astrocytes that may provide non-myelinating 
ensheathment of neuronal synapses259.  Since our cell proportion estimates only capture the 
major brain cell types, it is unable to inform changes in subpopulations of the major brain cell 
types.  Given the diversity of astrocytes as a cell population, our results could indicate 
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gliogenesis of relevant astrocyte subtypes (e.g., protoplasmic) or other glial cells that may not be 
captured by estimation of major brain cell types and imply participation of multiple glial cell 
types.  Interestingly, this hippocampal female MBR – EBR module was also significantly 
enriched for genes with high-CpG density promoters (HCPs) bearing histone H3K4me3 and 
H3K27me3 marks in brain, suggesting dynamic regulation of trauma-exposed group differences 
in female hippocampus via this epigenetic mechanism.  In summary, findings from this module 
suggest differences in individual response to trauma may involve glial processes supporting 
synaptic connectivity in the hippocampus, putatively via astrocyte-synapse interactions, 
specifically in females.  These processes, which are upregulated in the resilient MBR group and 
downregulated in the PTSD-like EBR group, may safeguard fear extinction learning in the MBR 
group and be implicated in impaired fear extinction learning in the EBR group.   
Next, consistent evidence across three network analyses, in both the SV- and cell-
adjusted full dataset and female subset of SV-adjusted data, endorsed increased expression of 
genes regulated by nuclear factor-κΒ (NFκΒ) in response to tumor necrosis factor-α (TNFα) and 
upregulation of genes after neuregulin-1 (NRG1) stimulation in the EBR group relative to the 
unexposed CON group in females, but not males.  In fact, the network analysis on full, cell-
adjusted data suggested this module may be associated with upregulation in the male MBR 
group; however, we note this was not endorsed by any other module identified in sex-stratified or 
full network analyses.  Stress has been shown to induce increased levels of proinflammatory 
cytokines, including TNFα, which activates NFκΒ, a key inflammatory transcription factor260.  
The TNFα signaling via NFκΒ pathway has various roles in the brain and is involved in 
regulating many signaling events, including growth/process development (e.g., dendritic 
arborization, axonal growth), and modulation of neuronal excitability/vulnerability of neurons to 
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excitotoxicity260,261.  In the hippocampus, the TNFα signaling via NFκΒ pathway has been 
implicated in regulating synaptic plasticity and memory261, and stress has been shown to activate 
NFκΒ signaling and decrease proliferation of neural stem-cell like cells in adult hippocampus262.  
Administration of an NFκΒ inhibitor has been demonstrated to block stress-induced inhibition of 
adult hippocampal neurogenesis, suggesting NFκΒ signaling may be a critical mediator of 
cellular (e.g., antineurogenic) consequences of stress that are linked to depressive-like 
behavior262.   
Relatedly, this module associated with female EBR – CON was also consistently 
enriched for genes up-regulated after stimulation with NRG1.  While this gene set was based on 
experiments conducted on a breast cancer cell line (MCF-7)263 and caution should be exercised 
in interpreting implications in brain, NRG1 is generally involved in activation of proliferation, 
survival, and differentiation.  Thus, upregulation of identified gene module members may reflect 
a general response to NRG1 that is not cell-line specific.  NRG1 is a member of the EGF family 
of receptor tyrosine kinase protein ligands with multiple isoforms and is known to be an 
important neurotrophic factor in the brain with key roles in neural development, synaptic 
plasticity, brain activity homeostasis, and neuroinflammation264,265.  Disruption of normal 
NRG/ERBB signaling has been implicated in impaired brain functioning and a number of 
psychiatric disorders264, with the NRG1 gene most notably implicated in schizophrenia266,267.  In 
hippocampus, NRG1 is suggested to regulate synapse development, particularly formation and 
maturation of inhibitory synapses, and has been shown to reduce expression of γ-aminobutyric 
acid (GABA) receptor α subunits in hippocampal slices268.   
In males, the module upregulated in the EBR group was associated with genes involved 
in the regulation of GABAergic synaptic transmission as well as those involved in the T-cell 
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receptor (TCR) signaling pathway.  In addition to its inhibitory role in synaptic transmission, 
GABAergic signaling plays a parallel role in the immune system269 and has been shown to 
inhibit adaptive inflammatory response to myelin proteins in an animal model of multiple 
sclerosis (i.e., experimental autoimmune encephalomyelitis [EAE])270.  Similarly, relevant to this 
male EBR-associated module, GABAergic signaling negatively regulates T cell-mediated 
immunity by its modulatory effect on T-cell proliferation and cytokine production271, and has 
been shown to inhibit TCR-mediated T-cell cycle progression in vitro272.  Thus, GABAergic 
signaling may putatively play a dual role in the regulation of both synaptic transmission and T-
cell programming in this male EBR module.   
The male EBR module was also significantly enriched for GPCR signaling and for genes 
with 3’UTR containing motif matching annotations for GR (glucocorticoid receptor, NR3C1), 
CEBPα (CCAAT/enhancer binding protein), and LFA-1 (lymphocyte function-associated 
antigen-1).  While GPCR signaling is ubiquitous, in the context of tissue and other significant 
enrichment hits for this module, fits a narrative of G-protein mediated signaling promoting initial 
adhesion of inflammatory T-cells on blood brain barrier endothelium (BBB) for transendothelial 
migration to hippocampus, with a putative role for LFA-1 in this process, under 
neuroinflammatory conditions273.  In parallel, stimulation of LFA-1 also modulates 
transcriptional programming for a number of key pathways, including activation of T 
lymphocyte differentiation into effector subsets Th1, Th17, and induced regulatory T cells, for 
tuning of T-cell functioning274; this modulation of transcriptional programming is the function 
directly implicated by our enrichment results.  In a similar vein, CEBPα is involved in 
inflammatory response and regulate expression of many pro-inflammatory genes shown to have 
increased expression after injury to aged brain275.  Finally, GR is an important mediator of stress 
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response that is implicated in stress-related psychiatric disorders.  Glucocorticoids in the 
hippocampus, distinct from their effect in hypothalamus, have been shown to play an important 
role in the development of hypothalamus-pituitary adrenal (HPA) axis hyperactivity276.  Of note, 
acute stress has been shown to increase interaction of GRs with their genomic targets in the 
hippocampus, in a gene-dependent manner277 and chronic stress has been implicated in 
dysfunction of GABAergic interneurons in the hippocampus278.   
In summary, our results in hippocampus have detected distinct, putatively sex-specific, 
transcriptional activity characteristic of the PTSD-like EBR group and differential response to 
trauma in females involving glial processes supporting hippocampal synaptic connectivity that 
may be implicated in fear extinction learning.  EBR in females was characterized by stress-
induced upregulation of the TNFα signaling via NFκΒ pathway and disruption of NRG1/ERBB 
signaling, which may be involved in dysregulated synaptic plasticity and development in the 
hippocampus.  Notably, these mechanisms may be implicated in the formation and maturation of 
inhibitory GABAergic synapses, with consequences for modulation of neuronal excitotoxicity.  
EBR in males was explicitly associated with increased regulation of GABAergic synaptic 
transmission and was also characterized by upregulated T-cell receptor signaling.  Additionally, 
three transcription factors implicated in stress, inflammatory response, and T-cell functioning, 
namely GR, CEBPα, and LFA-1, were identified as candidates that may coordinate these 
processes.   
 
Amygdala 
 While no group differences were observed in brain cell subtype proportions, cell 
composition analyses revealed prominent sex differences in the distribution of amygdalar cell 
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subtype proportions, such that females, regardless of group, showed significantly greater 
variance in distribution of relative cell proportions for astrocytes (ast), neurons (neu), 
oligodendrocytes (oli), and oligodendrocyte progenitor cells (opc), compared to males.  The 
original Daskalakis et al. (2014)223 study that deposited this dataset did not mention controlling 
for or tracking cycle or conducting ovariectomies, indicating the female rats in this dataset were 
free-cycling.  Thus, the broader distribution of these cell proportions may potentially reflect 
sensitivity of these amygdalar cell types to gonadal steroid hormones.   
 Extensive sex differences are found at the cellular and physiological level in the 
amygdala, most notably in the posterodorsal medial amygdala (MePD), and are associated with 
organizational and activational effects of gonadal steroid hormones279-285; they are observed prior 
to puberty279,286,287, become more extensive during puberty288, and demonstrate steroid-
dependent plasticity during adulthood280-285.  In rat MePD, which is important for sex-specific 
behavior, studies have reported more neurons and astrocytes in males than in females, and 
additional sex differences in size and morphology of cell bodies and processes, which also differ 
by laterality281,286,287,289.  While not specific to amygdala, sexual dimorphism of oligodendrocyte 
response to sex hormones has been reported in cell culture with females consistently showing 
greater sensitivity and responsiveness to hormones than males290.  To our knowledge, brain 
region-specific differences have not yet been investigated.  
 Network analyses in amygdala detected both shared and sex-specific gene modules.  The 
resilient MBR group in both sexes was characterized by increased expression of ECM-relevant 
genes (e.g., cytoskeletal proteins) and upregulation of ECM organization/remodeling, with 
collagen fibril organization specifically implicated.  Additionally, enrichment for epithelial 
mesenchymal transition implicated enhanced migratory capacity and stem cell-like phenotype 
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with processes in the likeness of wound healing and tissue repair in response to stress-induced 
neuroinflammation291.  The second shared module was significantly associated with 
downregulation in EBR for both sexes and relative upregulation in females; thus, our results 
endorse this module to reflect group differences in response to trauma in females, but only 
supports downregulation of this module to be characteristic of the EBR group in males.   
With respect to the PTSD-like EBR group, this shared module was associated with 
downregulation of GPCR signaling, synaptic signaling/transmission, GABAβ receptor 
activation, and exploration behavior, as well as decreased regulation of insulin secretion by 
glucagon-like peptide 1, protein kinase A (PKA) signaling, and cAMP metabolic process.  GPCR 
signaling, PKA signaling, and cAMP metabolic processes are ubiquitous and involved in 
signaling transduction; in the cell, cAMP targets PKA, which serves as the principal effector 
mechanism for GPCRs linked to adenylate cyclase292.  The cAMP/PKA signaling pathway is 
involved in the regulation of glucose homeostasis293 and relevant to the decreased regulation of 
insulin secretion by glucagon-like peptide 1.  Additionally, the cAMP/PKA signaling pathway 
plays an essential, evolutionarily conserved role in the mediation of neural processing of threat-
related stimuli (i.e., fear learning), consolidation of fear memory, and fear-related behavioral 
response in the amygdala292.  Targeted activation of cAMP/PKA signaling in the lateral 
amygdala has been shown to increase neuronal excitability and lead to generalized fear294, while 
targeted inhibition of cAMP/PKA activity in the lateral amygdala immediately after fear 
conditioning impaired fear memory retention295.  Additionally, stress modulates fear memories; 
β-adrenoceptor-mediated activation of the cAMP/PKA pathway has been shown to enhance fear 
memory consolidation and glucocorticoids (GCs) interact with the noradrenergic signaling 
pathway to modulate this activation in the basolateral amygdala (BLA)292.  Targeted inhibition of 
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either β-adrenoceptor or cAMP/PKA in the BLA before or immediately post inhibitory 
avoidance training has been shown to block memory consolidation and administering a GR 
antagonist before this training was able to block the noradrenergic-dependent enhancement of 
memory retention296.  Fear learning and memory is also linked to other anxiety-related 
behavioral responses, including exploration behavior, which was also significantly 
downregulated in this module.  Thus, dysregulation of this pathway in the amygdala is directly 
relevant for pathogenesis of PTSD.   
 Furthermore, the module was associated with the downregulation of synaptic signaling, 
specifically implicating disrupted GABAβ receptor activation and opioid signaling in the EBR 
group.  GABAβ receptor activation in the BLA has been shown to inhibit glutamatergic 
excitatory transmission297 and is essential for maintaining balance between neuronal excitation 
and inhibition298.  Stress has been shown to disrupt GABAergic inhibitory signaling in the 
amygdala in a projection-specific manner, leading to hyperexcitability in the BLA, and this 
effect has in turn has been implicated in increased anxiety/depression, emotional dysregulation, 
and the development of psychiatric diseases299.  Relevant to PTSD, functional neuroimaging 
studies have identified increased activation of the amygdala as a neural correlate for PTSD 
symptoms258,300,301.  Opioid signaling in the amygdala, particularly by kappa-type opioid 
receptors (κ-OR), is also involved in modulation of synaptic signaling and circuitry underlying 
fear learning and anxiety-like behaviors302,303.  Notably, a key gene downregulated was 
prodynorphin (PDYN), which encodes a preproprotein that is processed into endogenous opioid 
peptides that preferentially bind to κ-OR302.  In line with our results, reduced PDYN mRNA 
expression in discrete nuclei of the amygdaloid complex was found in postmortem samples from 
subjects with major depression and bipolar disorder304.  Additionally, Pdyn gene knockout was 
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found to alter GABAA receptor expression in the amygdala, increase anxiety-like behaviors, 
305, 
enhance cue-dependent fear conditioning, and delay contextual fear extinction306.  Blockade of κ-
ORs before extinction trials also produced similar effects and in humans, subjects with a 
functionally relevant PDYN polymorphism showed reduced fear extinction and significantly 
blunted functional connectivity between the amygdala and ventromedial prefrontal cortex306.  
Thus, dynorphin/κ-OR signaling play a role in fear extinction and disrupted κ-OR signaling 
impairs extinction learning.  In all, disruption of GABAβ receptor activation and κ-OR signaling 
lead to dysregulation of synaptic signaling in the amygdala, which is implicated in PTSD-
relevant symptoms, including impaired fear extinction.   
 In males, one module was significantly associated with downregulation in EBR and 
relative upregulation in CON, suggesting that this module highlights EBR response to trauma 
exposure.  Accordingly, a number of the terms significantly enriched with the module were 
related to response a molecular factor, notably to lipid, hormone, and steroid hormone, 
implicating enrichment for genes downregulated in response to glucocorticoids (GCs).  This 
male-specific EBR module was also significantly associated with downregulation of 
neuropeptide hormone activity, which included decreased expression of cholecystokinin (Ckk), 
neuropeptide Y (Npy), and vasoactive intestinal peptide (Vip).  These neuropeptides define 
classes of BLA interneurons that provide feedforward and feedback inhibition to projection 
neurons and other interneurons locally and are likely to be involved in higher-order 
contextualized behavior such as fear extinction307,308.  Thus, downregulation of these 
neuropeptides may be indicative of a decrease in these inhibitory amygdalar interneurons and 
disruption of excitatory/inhibitory balance.   
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Of these neuropeptides, NPY has been studied the most in relation to stress-related 
psychiatric disorders, as its release is induced by stress and has anxiolytic properties309.  Notably, 
a study of NPY using the same predator-scent stress (PSS) paradigm found lower NPY levels in 
the amygdala of the male EBR group compared to MBR or CON and showed administration of 
NPY one hour post-exposure to significantly reduce prevalence rates of EBR and trauma-cue 
freezing responses compared to controls310.  This suggests 1) downregulation of NPY is a robust 
characteristic of EBR directly linked to the behavioral response, and 2) NPY may serve not only 
as a diagnostic marker but also as a treatment candidate that can prevent development of PTSD-
like symptoms and promote resilience.  Interestingly, low NPY expression may be a 
predisposing risk factor.  A human genetic imaging study identified an NPY haplotype predictive 
of NPY mRNA expression in postmortem brain and lymphoblast and plasma NPY levels; using 
functional (fMRI and PET) imaging, they found low NPY haplotype individuals exhibited 
greater amygdalar reactivity in response to threat-related facial expression, had lower activation 
of pain/stress-induced μ-opioid system activation, and reported more negative emotional 
experiences during a painful stressor compared to high NPY haplotype individuals311.   
The male EBR module was also characterized by decreased expression of genes regulated 
NFκΒ in response to TNFα, which is the opposite direction of effect seen in hippocampus for the 
female EBR group.  Both the hippocampus and amygdala are stress-sensitive brain regions 
where NFκΒ plays a critical role in memory and is necessary for fear memory consolidation and 
reconsolidation312-314.  However, the exact region- and sex- specific differences in downstream 
effects of TNFα/NFκΒ signaling are unknown and require further investigation.  In sum, blunted 
GC response, disrupted inhibitory modulation of amygdalar circuitry, diminished NPY levels, 
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and dysregulation of genes downstream of TNFα/NFκΒ signaling are implicated in the male 
EBR group.   
More PTSD-relevant modules were identified in females; two modules (based on cell and 
SV-adjusted female subset) were associated with upregulation in MBR and downregulation in 
EBR, with the cell-adjusted module largely overlapping with the shared module identified in the 
full, cell-adjusted dataset.  This module was significantly enriched for the previously identified 
gene sets and was also enriched for additional terms.  Notably, significant enrichment for 
inhibition of insulin secretion by adrenaline/noradrenaline and behavior/associative learning 
elaborated a potential role for nor/adrenergic signaling in glucose homeostasis and strengthened 
the implications in fear learning and anxiety-related behavioral response.  Additionally, 
downregulation of dopamine receptor signaling, specifically for dopamine D2 receptor (Drd2), 
was significantly associated with this module.  The DRD2 gene is a popular gene candidate for 
PTSD and a meta-analysis of dopaminergic system genes identified a significant association for 
DRD2 rs1800497315.  Other genetic variants of DRD2 have also been implicated as a risk factor 
for PTSD, such as the A1 allele of the TaqA1/A2 polymorphism316,317 and C957T SNP 
(rs6277)318,319.  Dopaminergic signaling plays an important modulatory role in fear 
learning/memory and anxiety.  D2 receptors in the amygdala are endorsed to have context-
specific effects and an important role in regulating fear/anxiety responses320,321, with putatively 
differential functions in the central versus the lateral amygdala322, which receives key 
dopaminergic innervations from the ventral tegmental area323 and mediates dopaminergic gating 
of LTP induction necessary for fear conditioning324.  Notably, dopaminergic innervation of the 
amygdala is suggested to be more responsive to stress exposure than other limbic brain 
regions325, implying dopamine signaling in the amygdala may be important in stress response.  
76 
 
Thus, differential dopaminergic and GABAergic signaling in the amygdala may underlie 
important group differences in the modulation of fear learning and memory between resilient and 
PTSD-like females.   
The second female-specific module strongly endorses Srf as a key driver for trauma-
exposed group differences in the female amygdala.  In the adult brain, the Srf transcription factor 
activates immediate early genes (IEGs) and mediates cytoskeletal dynamics at neuronal 
processes326.  Enrichment results support differential regulation of both these effects, which 
suggests fundamental group differences in experience-dependent modulation of synaptic 
plasticity involving structural changes327; in amygdala, this has implications for long-term fear 
learning and memory.  Notably, the top hit in the C2 CGP collection indicates enrichment for 
genes downregulated in neurons after Npas4 knockdown, suggesting downstream effects of Srf 
disruption in the female EBR group may involve disruption of Npas4 activation.  In the 
amygdala, Npas4 expression was found to be selectively induced under conditions of associative 
learning and is suggested to be important for fear memory consolidation/reconsolidation328.  It 
has been demonstrated to regulate activity-dependent development of GABAergic inhibitory 
synapses via transcriptional regulation of the activity-dependent genes directly involved329, 
which fits the theme of disrupted excitatory-inhibitory balance in the amygdala.  Interestingly, 
cross-disorder investigation of transcriptome-wide dysregulation in postmortem brain of autism 
spectrum disorder (ASD), schizophrenia (SCZ), and bipolar disorder (BP) also identified NPAS4 
and other classic early response genes in a neuronal module differentiating BD and SCZ from 
ASD330, suggesting disruption of fundamental experience-activated plasticity mechanisms in 
stress-related neuropsychiatric disorders.  Continuing with the theme of group differences in 
excitatory-inhibitory balance, the next top enrichment hit in the C2 CGP collection was for genes 
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upregulated after NRG1 stimulation, suggesting NRG1 stimulation in the female MBR group.  
NRG1/ErbB4 signaling was found to be critical in the maintenance of GABAergic activity in the 
BLA, and this was associated with modulation of anxiety-like behaviors331.  Moreover, 
administration of NRG1 into the BLA had anxiolytic effects and enhanced GABAergic 
neurotransmission in high-anxiety mice331, suggesting a protective role of NRG1 stimulation in 
the MBR group.  Since the C2 CGP gene set collection does not include gene sets for 
perturbations in the opposite direction we cannot confirm what implications Npas4 upregulation 
and NRG1 inhibition may carry.   
Additionally, the module was indicated for differential expression of genes regulated by 
TNFα signaling via NFκΒ.  This is in line with our results for amygdala in the male EBR group, 
which was also characterized by downregulation of this gene set.  However, opposing direction 
of effect was observed for this gene set (of genes regulated by TNFα signaling via NFκΒ) in the 
female EBR group across amygdala and hippocampus.  Surprisingly, inspection of overlapping 
gene module members revealed there were more genes overlapping between the hippocampal 
and amygdalar modules with opposite directions of effect in females than between the male and 
female amygdalar modules with same direction of effect, suggesting putative sex and brain 
region-specific regulation in response to TNFα signaling via NFκΒ.  The different direction of 
effect between amygdala and hippocampus in females parallels previous studies demonstrating 
stress to increase synaptic plasticity, BDNF levels, and induce dendritic hypertrophy in the 
amygdala, while having the opposite effect in hippocampus and medial prefrontal cortex332-335.  
This is also endorsed by the one amygdalar module, detected in females, associated with 
upregulation in EBR relative to the unexposed CON group; this female EBR module was 
characterized by upregulation of genes involved in the ECM, stem cell/NPC proliferation, 
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positive regulation of neuron differentiation, and, positive regulation of dendritic spine 
development.  Thus, TNFα signaling via NFκΒ may be involved in the regulation of stress-
mediated synaptic/structural plasticity in both the hippocampus and amygdala, but have region-
specific effects.  Additionally, there may be more nuanced sex differences in genes/processes 
altered by TNFα signaling via NFκΒ.   
In summary, our results in amygdala support fundamental sex differences in cell 
composition that may be significantly influenced by sex hormones.  While a number of sex-
specific modules are endorsed, some group-relevant modules were shared across sexes.  The 
resilient MBR group was characterized by upregulation of ECM organization/remodeling, 
illustrating processes similar to wound healing and tissue repair in response to stress-induced 
neuroinflammation in the amygdala.  The PTSD-like EBR group was characterized by disruption 
of cAMP/PKA signaling, GABAβ receptor activation, and κ-OR signaling in the amygdala, 
which lead to dysregulation of synaptic signaling, impaired fear learning/memory, and anxiety-
related behavioral response.  Additionally, TNFα signaling via NFκΒ was indicated to play a 
major role in mediating stress-induced synaptic/structural plasticity in both sexes, but implicated 
for sex-specific downstream effects.  In males, EBR was also characterized by decreased 
expression of neuropeptide hormones, including those use to define classes of BLA interneurons, 
suggesting an additional male-specific mechanism involved in the disruption of 
excitatory/inhibitory balance.  Notably, downregulation of NPY may be directly linked to 
behavioral response and was only detected in male, but not female, amygdala.  On the other 
hand, in females, disruption of dopamine D2 receptor signaling and the Srf transcription factor 
were suggested to be key drivers for trauma-exposed group differences in the amygdala, where 
they are purported to shape differences in excitatory/inhibitory balance, differentially activate 
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IEGs and differentially mediate cytoskeletal dynamics in neuronal processes.  Together they may 
drive fundamental group differences in experience-dependent modulation of structural plasticity, 
and this has implications for long term fear learning and memory.  Additionally, we noted these 
PTSD-relevant modules in amygdala were significantly enriched for genes with HCPs bearing 
H3K4/27me3 in brain and were stronger in sex-stratified modules, except in the female module 
characterized by transcriptional regulation via Srf.  Thus, epigenetic regulation of transcriptional 
activity is endorsed in the amygdala, in both sexes.   
 
Blood 
 A module characterizing MBR in blood was identified for each sex.  In both sexes, this 
module was associated with general upregulation of wound healing processes, particularly 
platelet activation/hemostasis, and increased regulation of body fluid levels.  These processes 
were also identified using unadjusted expression levels, suggesting they are independent of MBR 
associations with other covariates modeled by SVs.  Interestingly, the unadjusted module also 
revealed that while upregulation of this module is shared across sexes in the MBR group, stress 
response in represented processes are sexually dimorphic in the EBR group, such that the module 
is upregulated in the female EBR and downregulated in male EBR group.   
The findings from this module for males directly mirror gene network analyses conducted 
in humans (using blood)68,336.  A prospective cohort study in US Marines pre- and post- 
deployment identified a module after combat trauma exposure (post-deployment) associated with 
PTSD resiliency signatures and an upregulation of genes involved in hemostasis and wound 
responsiveness336.  A more recent mega-analysis combined five independent blood transcriptome 
datasets and investigated three PTSD case-trauma-exposed control groups, stratified by type of 
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trauma exposure and sex, specifically men with combat trauma, men with interpersonal (IP) 
trauma, and women with IP trauma.  They identified a wound-healing and coagulation module 
downregulated in men with PTSD and combat trauma (relative to trauma-exposed control males 
with combat trauma).  This module was not relevant to women, which is in line with our results 
that indicated upregulation in both the female MBR and EBR groups.  Interestingly, the module 
also was not identified in men with IP trauma either, suggesting associated processes may be 
trauma-exposure specific.  A parallel validation study using a prospective female military cohort 
would enable us to similarly substantiate our female results in humans and help advance our 
understanding of the effect of trauma type on gene expression.   
Furthermore, our results suggest response to ROS/oxidative stress may be a candidate 
pathway to target in the study of sex differences in PTSD.  Sex differences in oxidative stress 
have previously been implicated in the study of cardiovascular diseases, which also have a 
sex/gender bias in disease prevalence337 and are often co-morbid with PTSD215,216.  Sex 
differences in response to oxidative stress have also been reported in the brain, notably in the 
hippocampus, in response to ethanol withdrawal338 and prenatal stress339.  Moreover, these sex 
differences appear to be evolutionarily conserved with reports of sex-specific adaptation to 
oxidative stress even reported in fruit flies340.   
The sex-stratified MBR – CON modules also endorsed some processes to be sex-specific.  
Vascular smooth muscle contraction is supported to be a process more relevant in males with 
PPP1CC identified as a candidate hub gene upregulated in the male MBR group.  Upregulation 
of the complement pathway and is supported to be more relevant in females with HNF1 and SRF 
found to be candidate transcription factors involved in coordinating this MBR module in 
females.  Additionally, a module identified only in females suggested female EBR may be 
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characterized by downregulation of immune and defense responses, which may involve 
impairment of coagulation, IL6-JAK-STAT3 signaling, and interferon gamma (IFNγ) response, 
with IFNγ particularly implicated as a key player involved in PTSD-like response to stress in 
females.  This is in line with a study that reported several sex-specific effects of IFNγ treatment 
on monoaminergic activity in key limbic regions and also demonstrated an IFNγ by stress (acute 
restraint stress) interaction to increase corticosterone levels in plasma, with larger effects in 
males341.   
In summary, we found wound healing processes and hemostasis to be upregulated in the 
resilient MBR group across sexes, but disrupted in a sexually dimorphic manner in the EBR 
group.  These findings, particularly in males, are consistent with the PTSD literature.  Response 
to oxidative stress and IFNγ are endorsed as candidate processes to target in the study of sex 
differences in PTSD.   
 
Cross-Tissue and Integrated Remarks 
Systemic stress hormones, particularly glucocorticoids (GCs), act in both blood and 
brain.  The hippocampus and amygdala are highly plastic and stress-sensitive limbic regions 
central for learning and memory associated with strong emotions – prominently fear memories, 
which have direct implications for PTSD symptoms.  Stress-induced TNFα/NFκΒ signaling, 
which plays a key role in the regulation of synaptic plasticity and fear learning/memory, is 
suggested to be a key pathway differentially disrupted in the EBR group in both brain regions.  
Although the specific downstream disruption is region-specific, a common theme of 
excitatory/inhibitory imbalance, involving disruption of GABAergic signaling, is advocated.  In 
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females, differential NRG1/ERBB signaling is implicated with region-specific effects in 
hippocampus and amygdala.   
Another notable commonality across hippocampus and amygdala was upregulation of 
ECM-regulated genes and ECM organization/remodeling in the resilient MBR group, in response 
to stress-induced neuroinflammation.  This is akin to a wound healing/tissue repair response in 
the brain and parallels significant upregulation of wound healing processes characteristic of 
MBR in blood.  Notably upregulation of ECM/wound healing is shared across sexes in both 
amygdala and blood, of both MBR groups.  While upregulation of ECM was identified in a 
female-specific hippocampal module, no MBR upregulated module was detected for males 
among adjusted, sex-stratified network analyses and there was generally more difficulty 
identifying PTSD-relevant hippocampal modules in males than females.  This challenge may 
stem from the loss of two male hippocampal samples during QC, which resulted in four male 
hippocampal samples in the EBR and MBR groups (8 samples total).  Thus, sex-specificity needs 
to be revisited with a larger sample size, especially in hippocampus.  In general, upregulated 
ECM remodeling and wound healing processes appears to be a common MBR response to 
stress/trauma that is observed across tissues and shared between sexes.   
As mentioned, a major limitation of this study was sample size, with some sex-stratified 
groups in brain having only four samples, namely male EBR and male MBR groups in 
hippocampus and female MBR group in amygdala.  By identifying co-expressed gene modules 
using an unsupervised network analysis approach and converging evidence across analyses based 
on sex-stratified and full datasets adjusted for SV and cell estimates (in brain) we were able to 
identify the gene modules that were most consistently supported across analyses.  Additionally, 
83 
 
further validation and investigation is required for cell estimation approaches, particularly in rats, 
due to lack of reference datasets.  
Our findings suggest both shared and sex-specific mechanisms underlying individual 
differences associated with vulnerability and resilience to trauma in blood and two key limbic 
areas, namely hippocampus and amygdala.  By disentangling cell composition from 
transcriptional changes, we found higher proportions of hippocampal oligodendrocytes in the 
EBR group for both sexes and also identified modules for transcriptional activity associated with 
group differences (ie., response to trauma) in the hippocampus that appeared to be sex-specific.  
By contrast, we found prominent sex differences, but no group differences, in amygdalar cell 
composition, and both shared and sex-specific modules representing PTSD-relevant 
transcriptional activity in the amygdala.  Across amygdala and hippocampus, both sex-specific 
and shared processes were relevant to an overarching framework for EBR implicating disrupted 
TNFα/NFκΒ signaling and excitatory/inhibitory imbalance in dysregulated synaptic/structural 
plasticity with important implications for fear learning and memory.  Our main finding in 
peripheral blood was consistent with the human literature and identified wound healing processes 
and hemostasis to be upregulated in the MBR group across sexes, but disrupted in a sexually 
dimorphic manner in the EBR group.  Unlike the varied characterization of the EBR group, 
characterization of MBR across blood, amygdala, and hippocampus suggests a common theme of 
upregulated wound healing and ECM remodeling shared between sexes.  In all, we identified 
differential oligodendrocyte proportions in hippocampus between PTSD-like EBR and resilient 
MBR, and identified processes and pathways that characterize the EBR and MBR-associated 
transcriptional changes across hippocampus, amygdala, and blood.  The sex-specific mechanisms 
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involved in EBR may contribute to the pronounced disparity in risk for PTSD, with women 





3.6 Figures and Tables 
 
Figure 3.1. Density plots of hippocampal oligodendrocyte estimates in EBR (purple) and MBR (green) 
groups, show significantly higher proportions in EBR compared to MBR group in both sexes (top).  Sex-
stratified density plots (bottom) confirm this group difference is not sex-specific.   
Note: EBR: extreme behavioral response (PTSD-like); MBR: minimal behavioral response (resilient). 
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Figure 3.2. Module enrichment plot for PTSD-relevant modules identified in network analyses of 
hippocampus.  Analyses on full expression dataset (both sexes) that has been (A) unadjusted for cell 
proportion estimates or surrogate variable (SV) estimates; (B) adjusted for cell proportion estimates; (C) 
adjusted for SV estimates.   
 (A) unadjusted: Module M2 consists of 104 genes; upregulation in EBR and downregulation in MBR 
groups in both sexes, and downregulation in female CON group.   
(B) cell-adjusted: Module M1 consists of 165 genes; upregulation in female EBR and male MBR groups 
with relative downregulation in CON group in both sexes.   
(C) SV-adjusted: Module M1 consists of 81 genes; upregulation in female EBR and downregulation in 
female CON group.   
The size and intensity of the circles correspond to the normalized enrichment score (NES) for the module 








Figure 3.3. Module enrichment plot for PTSD-relevant modules identified in sex-stratified network 
analyses of hippocampus.   
In the SV-adjusted female subset: (A) Module M2 consists of 144 genes and is associated with 
upregulation in EBR and relative downregulation in CON; (B) Module M1 consists of 170 genes and is 
associated with upregulation in MBR and downregulation in EBR.   
In the SV-adjusted male subset: (C) Module M2 consists of 101 genes and is associated with upregulation 
in EBR  
The size and intensity of the circles correspond to the normalized enrichment score (NES) for the module 







Figure 3.4. Gene-concept network plot for top GO terms enriched in female-specific MBR – EBR module derived from female subset of SV-
adjusted hippocampal expression data (M1: 170 genes).  Edges show associations between GO terms based on overlapping module genes.  Size of 
circles, representing GO terms, reflect gene count.   
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Figure 3.5. Density plots of amygdalar cell subtypes by sex, show prominent sex differences amygdalar cell composition, significant in astrocytes 
(ast), neurons (neu), oligodendrocytes (oli), and oligodendrocyte progenitor cells (opc), with females (blue) showing broad distributions (greater 
variance) and males (red) displaying sharp peaks.  Males had relatively higher neu proportion and lower ast, oli, opc proportions.   
90 
 
Figure 3.6. Module enrichment plot for PTSD-relevant modules identified in network analysis of cell-
adjusted amygdalar expression levels (both sexes).   
Module M2 (middle row) consists of 59 genes and is associated with upregulation in MBR and relative 
downregulation in CON, in both sexes.   
Module M3 (top row) consists of 55 genes and is weakly associated with downregulation in EBR groups 
of both sexes and upregulation in the female MBR group.   
The size and intensity of the circles correspond to the normalized enrichment score (NES) for the module 




Figure 3.7. Barplot for top GO terms enriched in (A) M2 and (B) M3 modules identified in network analysis of cell-adjusted amygdalar 
expression levels.   
x-axis and color transparency display -log10 of the Benjamini-Hochberg (BH)-adjusted p-value.  Dashed vertical line indicates BH-adjusted p-





Figure 3.8. Gene-concept network plot for (A) top REACTOME terms enriched in M3 module of cell-
adjusted amygdalar expression levels (55 genes), associated with downregulation in the EBR group for 
both sexes, with relative upregulation in the female MBR group; (B) top GO terms enriched in M2 
module derived from female subset of cell-adjusted amygdala (40 genes).  M2 is upregulated in MBR and 





Figure 3.9. Module enrichment plot for modules identified in sex-stratified network analyses of SV-
adjusted amygdalar expression levels in (A) females and (B) males.   
The size and intensity of the circles correspond to the normalized enrichment score (NES) for the module 






Figure 3.10. Module enrichment plot for modules identified in blood-based network.  Sex-stratified 
analyses of SV-adjusted data in (A) males and (B) females identified a shared module upregulated in 
MBR relative to CON.  This module was also identified in un-adjusted data in the (C) female subset and 
(D) full set (both sexes).  Notably, this module also revealed sex-specific group differences in the EBR 
group and a second module was identified in the SV-adjusted female subset relevant to downregulation in 
female EBR, relative to CON.   
The size and intensity of the circles correspond to the normalized enrichment score (NES) for the module 








Figure 3.11. Barplot for top GO terms enriched in M1 modules identified in sex-stratified network analyses of SV-adjusted blood expression 
levels in (A) males and (B) females.  Both modules were upregulated in the MBR group compared to the unexposed CON group.  
x-axis and color transparency display -log10 of the Benjamini-Hochberg (BH)-adjusted p-value.  Dashed vertical line indicates BH-adjusted p-






Figure 3.12. Interaction networks for M1 modules identified in sex-stratified network analyses of SV-adjusted blood expression levels in (A) 
males and (B) females.  Both modules were upregulated in the MBR group compared to the unexposed CON group.  





Table 3.1: Sample Characteristics by Tissue, Sex, and group, after processing 
 
Tissue Group Count 
Hippocampus 
EBR 9 (M: 4; F: 5) 
MBR 9 (M: 4; F: 5) 
CON 10 (M: 5; F: 5) 
Amygdala 
EBR 10 (M: 5; F: 5) 
MBR 9 (M: 5; F: 4) 
CON 10 (M: 5; F: 5) 
Blood 
EBR 15 (M: 7; F: 8) 
MBR 16 (M: 8; F: 8) 
CON 14 (M: 8; F: 6) 
 
Count contains number of samples included in analyses, after quality control and data processing, by 
tissue and group.  The breakdown by sex is included in parentheses (M = male; F = female).   
 
EBR: extreme behavioral response 
MBR: minimal behavioral response 




Table 3.2: Brain cell subtype markers used for cell proportion estimates  
 
Tissue ast end mic neu oli opc 
Hippocampus 386 352 338 476 460 334 
Amygdala 392 372 353 497 468 349 
 
Table reports the number of markers/genes expressed out of 1,000 markers per cell type, curated in 
BRETIGEA.  These markers were used for cell proportion estimates.   
ast: astrocytes; end: endothelial cells; mic: microglia; neu: neurons; oli: oligodendrocytes; opc: 




Table 3.3: ANCOVA Table - Hippocampal Oligodendrocytes EBR vs. MBR (n = 18) 
Terms Sum of Squares df Mean Square F p partial η2 
PTSD group 0.297 1 0.297 11.410 0.004*** 0.432 
Sex 0.001 1 0.001 0.053 0.822 0.004 
Residuals 0.390 15 0.026    
 










Table 3.4: Dunn test for Kruskal-Wallis multiple comparison - Hippocampal Oligodendrocytes 
 
Comparison  Z  p (unadj)  p (adj)  r
2 
CON - EBR -2.31 0.021 0.042 0.28 
CON - MBR 0.66 0.508 0.508 0.02 
EBR - MBR 2.89 0.004 0.011 0.46 
 
Note: p-values adjusted with the Holm method across group comparisons. 
Direction of effect for EBR vs CON comparison is the inverse of CON vs EBR comparison.  
Estimate of percentage variance explained r2, is calculated from the Z-score: , where N is the total number 
of observations.     
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Ratio Bg Ratio adj p geneID 
C2: CGP (top hit)          
NAGASHIMA_NRG1_SIGNALING_




UP 10/144 36/6477 2.7e-06 EGR1/JUNB/ARC/SIK1/NR4A2/EGR4/IER2/FOS/KDM6B/ZFP36 
H         
TNFA_SIGNALING_VIA_NFKB 17/52 94/2230 2.5e-10 
SGK1/EGR1/NFKBIA/JUNB/PER1/NFIL3/SIK1/CFLAR/NR4A2/
KLF4/IER2/FOS/IER5/KDM6B/GADD45B/KLF2/ZFP36 
C5: GO BP (top hits)          
CELLULAR_RESPONSE_TO_ 









Note: p-values adjusted with Benjamini-Hochberg method.   
Consider gene sets with a minimum of 10 and maximum of 500 genes.  Universe of background genes is based on overlap of genes expressed in 
hippocampus (n = 6,489) with gene set collection.   
First number in Gene Ratio refers to number of genes overlapping between term/gene set and module (i.e., gene count), while second number 
refers to number of genes overlapping between gene set collection and the module.   
First number in Background Ratio (Bg Ratio) refers to universe of expressed genes in the gene set, while second number refers to universe of 
expressed genes in the gene set collection.   
geneID lists genes in gene module that overlap with genes in gene set/term.   
All gene set collections (blue rows) were from the Molecular Signatures Database (MSigDB v6.2, released July 2018).   
C2: CGP = chemical and genetic perturbations sub-collection in curated gene set collection; 3,433 gene sets.   
H = hallmark gene set collection; 50 gene sets.   









Ratio Bg Ratio adj p geneID 
C2: CP REACTOME         
G_ALPHA_I_SIGNALLING_EVENTS 7/42 69/2433 0.021 CXCL12/RGS4/SST/PENK/PDYN/CNR1/RGS8 
GPCR_DOWNSTREAM_SIGNALING 10/42 178/2433 0.04 
CXCL12/PRKCE/NGEF/RGS4/SST/PENK/VIP/PDYN/CNR1/ 
RGS8 
SIGNALING_BY_GPCR 11/42 216/2433 0.04 
CXCL12/PRKCE/NGEF/RGS4/SST/WNT4/PENK/VIP/PDYN/ 
CNR1/RGS8 
C3 TFT     
GR_Q6 8/82 106/5191 0.041 TYRO3/WNT4/KLF5/DLX1/NNAT/CNTN4/NCAM1/LRRTM3 
CEBP_Q2_01 8/82 107/5191 0.041 STMN1/TNNC2/KLF5/DLX1/CALML4/PTEN/EFEMP1/LRRTM3 
LFA1_Q6 8/82 107/5191 0.041 WNT4/ANXA4/LCAT/DLX1/PDYN/ACVR1C/GSS/TMEM132E 
C5: GO          
REGULATION_OF_SYNAPTIC_ 
TRANSMISSION_GABAERGIC 5/96 20/6137 0.02 PRKCE/HAP1/PTEN/PLCL2/CNR1 
Note: p-values adjusted with Benjamini-Hochberg method.   
Consider gene sets with a minimum of 10 and maximum of 500 genes.  Universe of background genes is based on overlap of genes expressed in 
hippocampus (n = 6,489) with gene set collection.  First number in Gene Ratio refers to number of genes overlapping between term/gene set and 
module (i.e., gene count), while second number refers to number of genes overlapping between gene set collection and the module.  First number 
in Background Ratio (Bg Ratio) refers to universe of expressed genes in the gene set, while second number refers to universe of expressed genes in 
the gene set collection.  geneID lists genes in gene module that overlap with genes in gene set/term.   
All gene set collections (blue rows) were from the Molecular Signatures Database (MSigDB v6.2, released July 2018).   
C2: CGP = chemical and genetic perturbations sub-collection in curated gene set collection; 3,433 gene sets.   
C2: CP REACTOME = REACTOME gene sets in canonical pathways sub-collection in curated gene set collection; 674 gene sets.   
C3 TFT = transcription factor targets sub-collection in motif gene set collection; 615 gene sets.  Significant gene sets suggest module enrichment 
for genes having at least one occurrence of transcription factor binding sites for V$GR_Q6, V$CEBP_Q2_01, and V$LFA1_Q6 (v7.4 
TRANSFAC), in the regions spanning up to 4 kb around their transcription start sites.   





Table 3.7: Sex differences in distribution of amygdalar cell subtype proportions 
 
Cell subtype  
Levene’s Test for Equality of Variances Two-sample Kolmogorov-Smirnov Test 
F p D adj p 
ast 7.92 0.009 0.652 0.01 
end 1.92 0.18 0.319 0.52 
mic 0.011 0.92 0.357 0.52 
neu 23.28 4.87e-05 0.790 4.82e-04 
oli 5.47 0.027 0.571 0.037 
opc 5.18 0.005 0.719 0.003 
 
Note: In two-sample Kolmogorov-Smirnov test, p-values were adjusted using Holm’s method across cell 
subtypes.  Nominal p-value is shown for Levene’s test (df: 1,27).   
ast: astrocytes; end: endothelial cells; mic: microglia; neu: neurons; oli: oligodendrocytes; opc: 
oligodendrocyte progenitor cells.  
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Although post-traumatic stress disorder (PTSD) is moderately heritable, robust replicable 
genetic variants have eluded detection due to challenges managing heterogeneity and gene-
environment interactions.  Implementing an integrative systems level approach can help infer 
regulatory contexts for genetic variants and epigenetic marks.  In this study we conducted a 
preliminary investigation of the gene regulatory mechanisms underlying PTSD, specifically in 
African-Americans (AA) – an understudied, at-risk population.  We identified a putatively causal 
methylation quantitative trait locus (meQTL) located in the CAST gene; specifically, we found 
that rs151835 may be mediated by DNA methylation levels at cg13012653.  Further 
investigation revealed that CAST is located within topologically associated domains (TADs), 
suggestive of shared regulatory mechanisms across tissue, and a separate resource mapping the 
correlation of methylation levels (CpG) between brain and blood showed a significant correlation 
in CpG levels between brain and blood.  SNPs that do not endorse a causal effect on PTSD 
themselves may still have a functional effect regulating CpGs and gene expression levels (GE) 
involved in the pathophysiology of PTSD.  By including eQTL and meQTL SNPs as covariates 
in differential analyses, we identified differentially methylated (DM) CpGs and expressed (DE) 
genes that previously could not be detected.  On a related but separate note, we also identified 
one eQTM association independent of any SNP between a cell-specific DM (csDM) CpG, 
suggested to be on CD8+ T cells, and a DE gene.  Lastly, we examined overlap of these PTSD-
relevant associations found in blood with previous reports in relevant brain regions (ie., 
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frontal/temporal cortex, hippocampus) to identify a set of PTSD-relevant eQTL and meQTL 
associations in both blood and brain.  Continued studies examining the implications of this 
overlap may help identify PTSD-relevant eQTL and meQTL associations in blood that can make 
inferences in brain.   
 
4.2 Introduction 
While most people experience a traumatic event at some point in their lives, only a small 
subset develop PTSD over a lifetime, suggesting that trauma exposure is necessary but not 
sufficient for the development of PTSD and that pre-existing factors, such as genetics, contribute 
significantly.  Although PTSD is moderately heritable342-345, contributing genetic variants have 
been difficult to detect and replicate due to a number of challenges.  In addition to heterogeneity 
derived from the constantly evolving diagnostic criteria that encompass a diverse array of 
symptom presentations, PTSD has a highly complex, polygenic genomic architecture that needs 
to be considered in the context of trauma exposure346 – a prerequisite PTSD diagnostic criterion.  
In other words, there are a large number of genes with small effects that contribute in different 
and interactive ways (e.g., gene-by-gene (GxG) interaction) towards disease susceptibility, which 
is compounded by the importance of considering gene-by-environment (GxE) interactions to 
model how the environment (e.g., trauma exposure) influences PTSD risk by interacting with 
contributing genetic factors347.  Thus, identifying and assigning causality to specific genetic 
variants is challenging for polygenic, complex trait conditions in general348, and particularly 
complicated in the case of PTSD due to the importance of context (e.g., trauma type) and 
cumulative combination of both genetic and non-genetic factors.   
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One important consideration applied to genetic studies of PTSD is comparison of PTSD 
cases against similarly trauma-exposed controls.  However, single data-type approaches such as 
large-scale genome-wide association studies (GWAS) and candidate gene studies have still had 
limited success, to date, in identifying replicable risk variants39, due to the challenges of 
considering these interactions.  An integrative systems level approach that incorporates genomic, 
epigenomic, and transcriptomic data can help achieve a more thorough and informative 
interrogation of genotype-phenotype associations and put putative regulatory roles of genetic 
variants and epigenetic marks (e.g., methylated CpG sites) in context.   
Another challenge of genomic studies is confounding due to population stratification (i.e., 
population differences in SNP variation) in samples of diverse genetic ancestry.  To address this, 
populations based on ancestry are often analyzed separately and statistical techniques controlling 
for population stratification are used to increase likelihood of finding genetic variation relevant 
to the phenotype rather than spurious associations to ancestry markers.  However, much of the 
genomic literature has been grounded in studies of European-ancestry individuals and our 
understanding of genomic contexts derived from these studies cannot be generalized to other 
ancestry groups349.  Lack of population diversity in GWAS is a major concern in genomic 
medicine with significant implications for health disparities, and particularly recognized for 
those of African ancestry350-352; this lack of diversity has explicitly been recognized in genomic 
PTSD research as well353.  African ancestry populations have the greatest genomic diversity 
compared to all other world populations and a number of examples have illustrated the functional 
consequences and African-specific health implications, notably for cardiometabolic and immune 
traits relevant to diabetes, cardiovascular disease, obesity/inflammation, and autoimmune 
diseases354-357.   
105 
 
Ancestry-specific differences in genomic context may be due to population differences in 
allele frequency at functional genomic variants or other mechanisms involving other layers of 
genetic regulation.  A prominent example illustrating a fundamental immune system 
consequence of functional genetic variation is the Duffy Null polymorphism, which is > 90% 
difference in frequency between West Africans and European Americans and predictive of white 
blood cell and neutrophil count358,359.  Notably for epigenetic regulation, DNA methylation has 
been shown to contribute to population differences, with the majority of population-specific CpG 
sites associated with genetic variation360-363.  Such genomic variants, or methylation quantitative 
trait loci (meQTLs), underlie allele-specific methylation patterns at a given locus and are thought 
to mediate inter-individual methylation differences that may be invariant across tissues364.  In 
other words, since genetic variants/SNPs do not vary within an individual, DNA methylation loci 
regulated by these SNPs may share patterns across tissues.  Thus, identifying functionally 
relevant genetic variants (SNPs) that share regulatory contexts across tissues of interest (e.g., 
blood and brain) may provide insights into disease-relevant changes in less accessible tissues of 
interest (e.g., brain).   
In this study, we investigate the genomic context underlying DNA methylation and gene 
expression patterns associated with post-traumatic stress disorder (PTSD), specifically in African 
Americans, who have been shown to have greater conditional risk for developing PTSD 
following trauma exposure18.  Specifically, we implement an integrative -omics framework to 1) 
identify genetic variants (SNPs) that putatively regulate DNA methylation and gene expression 
in PTSD, 2) investigate methylated CpG marks associated with leukocyte gene expression 
relevant to PTSD, and 3) identify SNPs that putatively regulate DNA methylation and gene 
expression associated with PTSD in peripheral blood and determine if the same regulatory 
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context has been identified in relevant brain tissues in previous studies364,365, to infer PTSD-
associated changes that may be shared in both blood and brain.   
 
4.3 Methods 
Study Participants and Datasets 
Adult participants of the Detroit Neighborhood Health Study (DNHS; described 
previously) with available genotype, DNA methylation, and/or gene expression (GE) microarray 
data were included in this study.  Datasets were derived from whole blood samples that were 
processed to isolate DNA, for genotyping and DNA methylation assays, and RNA for gene 
expression measurements at the Applied Genomics Technology Facility (Wayne State 
University, Detroit).  Genotype, DNA methylation (DNAm), and GE were assayed using the 
Illumina OmniExpress, HM 450K, and HT-12 BeadChip arrays, respectively, in consenting 
DNHS participants.  For expression quantitative trait loci (eQTL) analyses, there were 81 
African-American (AA) participants with both genotype and GE data, balanced for sex and 
lifetime PTSD status.  For methylation quantitative trait loci (meQTL) analyses, there were 124 
AA participants with both DNAm and genotype data.  For expression quantitative trait 
methylation loci (eQTM; i.e., sites showing correlated expression and methylation) analyses, 
there were 99 participants (AA: n = 82) with both DNAm and GE data.  All controls were trauma 
exposed.  Trauma exposure and PTSD histories were collected via structured telephone 
interviews.   
Lifetime PTSD diagnosis was assessed by the well-validated self-report PTSD Checklist, 
Civilian Version (PCL-C)138-140 based on symptoms defined by the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (DSM-IV)14,108,142.  Participants who met all six 
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DSM-IV criteria in reference to their worst traumatic event or to a randomly selected traumatic 
event (if the participant experienced more than one trauma), were considered affected by lifetime 
PTSD.  The survey-based diagnoses were validated in a random subsample of participants via in-
person clinical interview and showed high internal consistency and concordance108,143.  Smoking 
status was defined as smoking at least one day within 30 days of survey data collection, as 
reported by the participant.   
 
Sample Processing 
 Genomic DNA was extracted from peripheral blood using the DNA Mini Kit (Qiagen, 
Germantown, MD).  DNA samples were bisulfite-converted using the Zymo EZ-96 DNA 
methylation kit (Zymo Research, Irvine, CA) and whole-genome amplified, fragmented, and 
hybridized to the Illumina Human Methylation 450K BeadChip array (Illumina, San Diego, CA), 
according to the manufacturers’ recommended protocols, as published previously148,149.  RNA 
was extracted from leukocytes using Leukolock kits (Ambion, Austin, TX) following the 
manufacturer’s alternative protocol, to preserve total RNA.  RNA samples that met quality 
control criteria for RNA quality and purity: RNA integrity number (RIN) ≥5 and 28s/18s ratio 
≥1.0, as determined by Agilent 2100 Bioanalyzer (Agilent, Wilmington, DE), and 260/280 ratios 
≥1.7, as determined by NanoDrop 1000 (ThermoScientific, Wilmington, DE), were used for 
gene expression profiling.  For microarray processing, 220ng of RNA from each participant was 
supplied to the Wayne State University Core facility, Applied Genomics Technology Center 





Quality Control, Processing, and Analysis of -Omic Data 
 An overview of the computational workflow, described in more detail below and 
referenced in each subsection, is summarized as a flow chart (Figure 4.1).  Unless otherwise 
indicated for genotype quality control (QC) and processing, all QC, processing, and analyses 
were conducted in R, version 3.5.1151, Bioconductor version 3.7153,154.   
 
Quality Control and Processing of Genotype Data 
Quality-control (QC), imputation, and calculation of ancestry PCs from genotype data are 
described in Duncan et al. (2017)39.  Briefly, QC procedures were conducted in PLINK366; 
samples and probes were removed based on the following criteria, sequentially: 1) Monomorphic 
SNPs and SNPs with missingness > 0.05 (i.e., call rate < 95%); 2)  Individuals with missingness 
> 0.02 (i.e., call rate < 98%); 3) Individuals with heterozygosity |Fhet| > 0.2 (autosomal 
heterozygosity deviation); 4) Individuals failing sex check; 5) SNPs with missingness > 0.02 
(call rate < 98%); 6) SNPs with differential missingness between cases and controls > 0.02; 7) 
SNPs failing Hardy-Weinberg equilibrium (controls: p < 1x10-6;  cases: p < 1x10-10).  Pre-
phasing and genotype imputation to the 1000 Genomes367 phase 1 reference panel was performed 
according to the PGC pipeline368 using SHAPEIT for phasing369 and IMPUTE2370,371 for 
imputation.  Imputation was performed with a chunk size of 3 Mb and default parameters on the 
full set of 2,186 phased haplotypes (release v3.macGT1, August 2012).   
Additional QC was conducted using the SNPRelate package372 to perform identity-by-
descent (IBD) relatedness analysis on 631 samples in the dataset to check for cryptic relatedness 
and duplicates, using probes retained after linkage disequilibrium (LD) -based SNP pruning (LD 
threshold = 0.2; kinship threshold ≥ 0.1).  IBD coefficients were computed using PLINK’s 
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method of moments procedure.  After removing 4 samples based on IBD analysis, 627 samples 
were retained, of which 596 participants self-reported as African-American and non-Hispanic.  
SNPs were limited to those with a minor allele frequency (MAF) > 0.1 for genetic association 
tests and eQTL/meQTL analyses.   
 
Quality Control and Processing of DNA Methylation Data 
QC and data processing for the DNHS 450K dataset followed the workflow described in 
Chapter 2.  Briefly, five samples were removed for gender discordance in the QC step, before 
ssNoob158,163 background correction, probe filtering based on detection (p-value > 0.001 in more 
than 10% of samples155) and cross-reactive probes159 (i.e., cross-hybridized between autosomes 
and sex chromosomes), and beta-mixture quantile (BMIQ) normalization (ChAMP161,162).  To 
control for technical artifacts (e.g., sample processing and imaging batch effects), four PCs based 
on non-negative control probe signal intensity156 were removed from BMIQ-normalized M-
values (i.e., logit-transformed beta-values), while controlling for lifetime PTSD and age.  PC 
correlation heatmaps were used to check for successful removal/reduction of batch effects, 
especially chip and row effects, while maintaining signal from biological variables.   
 
Leukocyte Composition and Ancestry Estimation Based on 450K Data 
Leukocyte composition was estimated on batch-adjusted beta-values using robust partial 
correlation (RPC; robust multivariate linear regression, non-constrained projection) as the 
deconvolution algorithm and the EpiDISH128 reference database, which is informed by cell-type 
specific DNase hypersensitive sites (DHS; based on the NIH Epigenomics Roadmap database166) 
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and is optimized for discriminating granulocytes, CD14+ monocytes, CD8+ T cells, CD4+ T cells, 
CD19+ B cells, and CD56+ natural killer cells.   
 DNAm-based ancestry principal components (PCs) were derived on cleaned beta-values 
after regressing out sex and age from batch-adjusted M-values.  Ancestry PCs were calculated on 
a subset of 2,317 ancestry informative CpG probes included in two published ancestry 
informative CpG lists that accounted for confounders168 and that included probes within 10 base 
pairs (bp) of single nucleotide polymorphisms (SNPs)169.  The first 2 PCs based on this subset of 
probes were used as ancestry PCs after checking for strong association with self-reported race.  
Scatter plots confirmed effective separation of self-reported race.   
 
Quality Control and Processing of Gene Expression Data 
Raw control and sample probe profiles were imported into R.  Samples were removed 
based on low sample quality and QC metrics (i.e., RIN ≤ 5; inter-array correlation (IAC), std dev 
> -2.5; sex check fail).  Out of 129 samples, 123 were retained after sample QC.  (One removed 
for not having RIN data, 4 removed as outliers based on inter-array correlation (IAC), 1 removed 
for failing sex check.)  Pre-processing involved normexp background correction using negative 
control probes, quantile normalization, and log2 transformation using the neqc function in the 
limma package228,229.  Probes were filtered based on expression (detection p-value < 0.01 in at 
least 10% of subjects) and processed expression data was adjusted for plate effects, while 
accounting for lifetime PTSD, sex, and age, using ComBat165 in the sva package.   
Probes were annotated based on three database sources available on Bioconductor: 1) 
ReMOAT re-annotated Illumina HT12-v4 probe annotations in illuminaHumanv4.db230; 2) 
UCSC Known Gene table on the hg19 genome assembly, mapped by Entrez Gene ID 
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(TxDb.Hsapiens.UCSC.hg19.knownGene); and 3) Illumina HT12-v4 annotations from Ensembl 
via BioMart (GRCh37.p13/hg19. Ensembl 95).   
 
Leukocyte Composition Estimation Based on HT-12 Data 
Relative leukocyte subtype proportions were estimated using the CellCODE approach to 
compute surrogate proportion variables (SPVs)232, which reflect relative differences in cell-type 
composition between groups.  SPV estimation was based on ComBat-corrected expression data 
and guided using tag markers for B cells, CD8+ T cells, CD4+ T cells, natural killer (NK) cells, 
monocytes, and granulocytes, based on HaemAtlas373, a publicly available, pure cell reference 
dataset built on the Illumina HumanWG-6 v2 BeadChip array (ArrayExpress E-TABM-633).   
Before use in tag marker selection, the HaemAtlas dataset was corrected for array effects while 
accounting for cell-type using ComBat and probes were filtered to exclude probes that mapped to 
sex chromosomes and that had poor annotation quality (i.e., inconsistent chromosome mapping 
across annotation databases, UCSC knownGene table, hg19 or Ensembl 95).  Expression of 
retained probes were averaged within each cell type to build the reference dataset used for tag 
marker selection. 
Up to 10 tag markers were selected for each cell type based on ranking by highest 
expression value that exceeded the other five cell types by a cutoff of 1 in log2 space.  The tag 
markers estimated to be the most transcriptionally stable (80% of markers) for each cell type 
were used to guide singular value decomposition (SVD) of the sex-stratified dataset structure and 
the first right singular vector (i.e., eigengene) was used as the SPV corresponding to relative 
proportion for that cell type.  The SPV estimates were incorporated into the linear model for our 




Data Preparation for Cross-Omic Analyses 
Additional data preparation steps were conducted before cross-omic analyses.  HT12 v4 
expression probes were further filtered based on four criteria.  Probes were removed if they 1) 
had poor quality annotation, based on no mapping to Entrez Gene ID and inconsistent 
chromosome mapping between the Illumina annotation and either UCSC knownGene table 
and/or Ensembl annotation sources; 2) mapped to non-autosomal chromosomes (i.e., sex 
chromosomes); and 3) overlapped with SNPs that had MAF ≥ 0.01 in the African 
superpopulation, based on 1000 Genomes Project, Phase 3 data374.  Additionally, for genes that 
mapped to multiple probes, the probe with the highest average intensity/expression level was 
selected to represent the gene (Entrez Gene ID) for 1:1 probe:gene mapping.  HM450K 
methylation probes were also filtered based on mapping to non-autosomal chromosomes and 
overlap with SNPs that had MAF ≥ 0.01 in the African superpopulation.  In total, 1,102,581 
SNPs, 9,055 genes, and 328,492 CpGs were retained for analyses.  
Inverse-rank normalized residual expression, adjusted for lifetime PTSD, sex, age, 
ancestry PCs, CellCODE SPV estimates (CD8+T cells, CD4+T cells, B cells, NK cells, 
monocytes, and granulocytes), current smoking, and RNA integrity number (RIN), was used for 
eQTL and eQTM analyses.  Similarly, inverse-rank normalized residual M-values (logit-
transformed beta values), adjusted for lifetime PTSD, sex, age, DNAm-based ancestry PCs, RPC 
cell estimates (CD8+T, CD4+T, NK cells, monocytes, B-cells), and current smoking, was used 
for meQTL and eQTM analyses.  Genotype-derived ancestry PCs were used for covariate 
adjustment in eQTL and meQTL analyses and DNAm-based ancestry PCs were used for eQTM 




xQTL Association Analyses: PTSD-Agnostic eQTL. meQTL, and eQTM mapping 
Cross-omic quantitative trait loci (xQTL) associations were identified using the 
BootstrapQTL375 package, built on the MatrixEQTL376 framework, separately for SNP-GE (cis-
eQTL), SNP-CpG (cis-meQTL), and CpG-GE (cis-eQTM) associations.  Briefly, the 
BootstrapQTL method implements a hierarchical procedure to control for multiple testing of 
variants at each gene (local correction) before controlling for multiple testing across all genes 
(global correction), and also corrects for effect size overestimation using a bootstrap method375.  
The cis-eQTL and cis-eQTM analyses were conducted on the full set of genes and SNPs within 
250kb of the Illumina Human HT12-v4 probe ends, mapped to expressed probes on the HT12 
BeadChip array.  To alleviate the burdensome number of associations between 1,178,530 SNPs 
and 328,492 CpGs, meQTL association analyses were conducted in two sets: set 1 was filtered 
by SNPs identified as eQTLs in eQTL association analyses and set 2 was conducted on an LD-
pruned set of SNPs (i.e., those in linkage equilibrium), which was identified by iteratively 
removing adjacent SNPs that exceed an LD threshold of 0.8 in a sliding window.  The first 
meQTL set was used towards cross-omic integrative analyses (i.e., identification of SNP-CpG-
GE associations) and the second, LD-filtered meQTL set was used for meQTL-specific 
differential methylation analyses.  Both meQTL sets used a distance threshold of 100kb between 
SNPs and CpGs.  
Since CpGs and genes with eQTL/meQTL associations are associated with multiple 
SNPs, some of which may be in linkage disequilibrium, we identified a set of effective eQTL 
and meQTL associations for leading SNPs based on best (minimum) p-value per CpG or gene.  
For CpGs and genes that had associations in both directions (i.e., both positive and negative 
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directions of effect), we identified secondary SNPs with minimum p-value among SNPs with 
opposite direction of effect from the primary leading SNP per CpG/gene.  We used these 
effective sets of associations in subsequent differential analyses (Figure 4.1).  Additive modeling 
was used for genotype.   
 
Genetic Association Tests for lifetime PTSD 
Simple genetic association tests based on Cochran-Armitage test (1 df) and conventional 
Pearsonian test (2 df; 3x2 contingency table) were run on the larger DNHS genotype dataset of 
African-American participants (n = 596) for SNPs with MAF > 0.1, using snpStats to identify 
SNPs suggestively associated with lifetime PTSD (p < 0.01 for either association test).  Genomic 
inflation factor (λ) for both tests was 1.03.   
 
Differential Methylation and Expression Analyses for lifetime PTSD (without accounting for 
SNP) 
Genes independent of eQTLs (in eQTMs) were identified as PTSD-relevant if they were 
significantly associated with lifetime PTSD based on standard differential expression analysis 
(FDR < 0.05) conducted on the subset of eQTM participants (n = 99).  Gene expression was 
modeled as a function of lifetime PTSD, accounting for sex, age, DNAm-based ancestry PCs, 
current smoking status, RIN and CellCODE SPVs.  The linear model was fit genewise (on the 
full set of genes, n= 9,055) using an empirical Bayes approach in limma to compute moderated t-
statistics and log2 fold change
228,238.  CpGs independent of meQTLs (in eQTMs) were identified 
as PTSD relevant if they were significantly associated with lifetime PTSD based on cell-type 
specific differential methylation (csDM) analysis (FDR < 0.05) conducted on the full DNHS 
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HM450K dataset (n = 174).  This recently published approach, described in Zheng et al. 
(2018)209, models beta-values as the interaction between each leukocyte subtype proportion 
(RPC-based cell estimate) and lifetime PTSD, accounting for sex, age, current smoking, and 
DNAm-based ancestry PCs.   
 
Causal Inference Test and Mediation Analyses for lifetime PTSD 
Causal inference test (CIT)377 and mediation analyses378 were conducted for identified 
eQTL and meQTL associations separately at SNPs suggested to associate with lifetime PTSD in 
our larger genotype dataset of African-American participants (n = 596).  CIT implements formal 
statistical hypothesis testing to quantify uncertainty in causal inference using an intersection-
union test that combines a series of four statistical tests for a “chain” of mathematical conditions 
to form an omnibus test that determines if a potential mediator is causal for the trait377.  Causal 
mediation is supported by a significant omnibus p-value (p_cit < 0.05), which represents the 
maximum of the p-values for the four component tests.   
Initial CITs were run without permutation using the cit package, accounting for 
covariates in the model.  For CITs on eQTL associations, covariates included were sex, age, 
CellCODE SPVs, current smoking and RIN.  For CITs on meQTL associations, covariates 
included were sex, age, RPC cell estimates and current smoking.  For significant causal hits 
identified in initial CIT, follow-up CIT was run with 10,000 permutations, based on the original 
code published in Millstein et al. (2009)377.   
Additionally, causal mediation analyses were run with non-parametric bootstrapping 
(10,000 Monte Carlo draws) for significance testing and estimation of the average causal 
mediation effects (ACME), using the mediation package378.  In the outcome model for these 
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analyses, lifetime PTSD is regressed on both the SNP and mediator (GE or CpG), using a 
binomial model with probit link function, to confirm that the mediator is a significant predictor 
of lifetime PTSD and that the significant association between lifetime PTSD and SNP is lost (full 
mediation) or greatly reduced (partial mediation) after accounting for the mediator.  Causal 
mediation analysis was conducted for treatment comparisons between control genotype with no 
minor alleles to one minor allele and between genotype with no minor alleles to two minor 
alleles.  In addition to estimating ACME, mediation analysis reports the average direct effects 
(ADE), total effect (tau; combined indirect and direct effects), and the ratio of these estimates 
(i.e., proportion mediated).   
Adjusted expression levels and M-values were used for both CIT with permutation and 
causal mediation analyses.  Expression levels were adjusted for sex, age, ancestry PCs, 
CellCODE SPVs, current smoking and RIN, while accounting for lifetime PTSD, and inverse-
rank normalized.  M-values were adjusted for sex, age, ancestry PCs, RPC cell estimates, and 
current smoking, while accounting for lifetime PTSD, and inverse-rank normalized.   
 
Identification of xQTL associations relevant to lifetime PTSD 
To investigate relevance of xQTL associations to PTSD, we identified CpGs 
differentially methylated (DM) and genes differentially expressed (DE) by lifetime PTSD.  Since 
SNPs significantly influence associated DNA methylation levels (CpGs) and gene expression 
levels (GE), differential methylation and differential expression was considered for eQTMs 
independent of SNPs (i.e., without associated meQTL or eQTL) separately from CpG and GE 
significantly associated with meQTLs and eQTLs.  As described above, CpG and GE 
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independent of meQTLs and eQTLs, respectively, were identified using cell-specific DM and 
standard linear model DE analyses that did not account for SNP as a covariate.   
CpGs and gene expression probes associated with meQTLs/eQTLs were identified as 
PTSD-relevant if they were significantly associated with lifetime PTSD while accounting for 
meQTL/eQTL, based on two tests: 1) the relevant component test in the CIT framework 
(association conditioned on SNP; without permutation); and 2) likelihood ratio test comparing 
models with and without lifetime PTSD as a predictor (p < 0.01 for both tests).  Overlap between 
PTSD-relevant xQTL associations identified genomic variants that acted as both eQTLs and 
meQTLs (putatively regulating both DNAm and gene expression) and significant SNP-CpG-
gene associations.  Finally, PTSD-relevant associations were queried against previously 
published xQTL associations in brain tissues (i.e., hippocampus and frontal/temporal 
cortex)364,365 to determine if any putatively share regulatory contexts in blood and brain.   
 
4.4 Results 
Identification of xQTL associations in the DNHS 
In cis-eQTL analyses, 3,476 significant cis-eQTLs were identified for 3,421 unique SNPs 
(MAF > 0.1) among associations between 9,055 genes and 1,102,581 SNPs.  Of the 3,421 SNPs 
associated with gene expression (GE), 4,075 significant SNP-CpG (cis-meQTL) associations 
were identified for 1,649 SNPs and 343 CpGs.  These SNPs were associated with 117 unique 
genes through their cis-eQTL association and considered cis-e/meQTLs associated with both 
CpG and GE.  In our second meQTL analysis on LD pruned subset of SNPs (n = 285,812), 
35,997 significant cis-meQTLs were detected.  Across both sets of meQTL analyses, 39,668 
distinct meQTLs were detected and 1,649 SNPs were identified as cis-e/meQTLs with both 
118 
 
DNAm and GE associations.  There were 4,104 e/meQTL associations for these SNPs to 343 
CpGs and 117 genes.  After selecting strongest associations based on minimum p-val per 
CpG/gene (in each direction of effect), there were 265 eQTL and 18,415 meQTL associations in 
effective xQTL sets used in subsequent analyses combining xQTL and differential analyses (i.e., 
Step 2 in Fig. 4.1).   
Additionally, eQTM analyses detected 356 significant CpG-GE associations.  Of these, 
the CpGs in 167 eQTM associations also had meQTL associations and GE in 97 eQTM 
associations also had eQTL associations.  Investigating the overlap across eQTL, meQTL, and 
eQTM associations identified 1,512 significant SNP-CpG-GE associations.  These cross-omic 
associations consisted of 985 unique eQTL associations, 1,500 meQTL associations, and 80 
eQTM associations, across 973 SNPs, 79 CpGs, and 42 unique genes.   
 
Identification of individual PTSD-relevant features 
Genetic association tests (1 and 2 df) were used to identify candidate SNPs suggestively 
associated with lifetime PTSD.  In the full SNP set (typed and imputed), 19,327 out of 1,182,646 
SNPs with MAF > 0.1 were identified to have a suggestive association with lifetime PTSD 
(p<0.01).  Genetic association tests on the LD pruned subset of SNPs (n = 285,812) detected 
4,717 SNPs that were suggestively associated with lifetime PTSD (p < 0.01).   
Standard linear model differential expression analyses identified 1,104 DE genes 
associated with lifetime PTSD (FDR < 0.05).  Due to challenges identifying differentially 
methylated (DM) genes using standard linear model analyses, we implemented a recently 
published cell-specific DM approach reported to achieve high sensitivity and specificity in 
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scenarios where DM was not identified209.  Using this approach, we identified 8,356 csDM CpGs 
associated with lifetime PTSD in at least one of the leukocyte subtypes (FDR < 0.05).   
 
rs151835 identified as a putative causal variant for PTSD mediated by DNAm levels at 
cg13012653 
There were 26 cis-eQTL SNPs suggested to be associated with lifetime PTSD based on 
genetic association tests conducted in the larger genotype dataset.  However, none of the genes 
among candidate cis-eQTL associations were identified as differentially expressed by lifetime 
PTSD and no causal variants were identified in initial CITs for cis-eQTL associations.  In 
contrast, among cis-meQTL associations, there were 268 SNP-CpG associations for 212 SNPs 
suggested to be associated with lifetime PTSD.   
One cis-meQTL, rs151835, was identified as a putative causal variant for PTSD mediated 
by DNAm levels at cg13012653 in initial CIT (p_cit = 0.026; Table 4.1).  Participants in the 
lifetime PTSD group were more likely to have the G/G genotype at rs151835 (Cochran-Armitage 
Test: χ2(1, N = 596) = 6.87, p = 0.009; Pearsonian Test: χ2(2, N = 596) = 7.34, p = 0.025), and 
this genotype was associated with lower methylation levels at cg13012653 (meQTL: corrected β 
= -0.8, SNP p < 2.7e-7, CpG p < 1.4e-6), contributing to lower methylation levels in the PTSD 
group (LRT: p = 0.29; CIT: p = 0.026; Figure 4.2).  This cis-meQTL, rs151835, is an intron 
variant located 7,852 bp upstream of cg13012653.   
Follow-up CIT with 10,000 permutations using the original test published in Millstein et 
al. (2009)377 continued to support a causal pathway (p = 0.048).  Causal mediation analyses for 
both comparisons (mod1: comparing 0 vs 1 minor alleles; mod2: 0 vs 2 minor alleles) showed a 
significant effect of cg13012653 on the relationship between rs151835 and lifetime PTSD 
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(mod1: ACME = -0.1, p = 0.024; mod2: ACME = -0.2, p = 0.026) with no direct effect of SNP 
(mod1: ADE = -0.05, p = 0.50; mod2: ADE = -0.12, p = 0.53) and a significant total effect (tau: 
mod1: p = 0.026; mod2: p = 0.023).  Thus, a total mediation effect of cg13012653 on rs151835 
was supported for both comparisons (Figure 4.3) and all CIT and mediation analyses consistently 
supported rs151835 to have a causal effect on PTSD mediated via cg13012653.   
 
Integrated xQTL and differential analyses identify putative PTSD-relevant associations 
SNPs that do not endorse a causal effect on PTSD themselves may still have a functional 
effect regulating CpGs and genes involved in the pathophysiology of PTSD.  By integrating 
xQTL and differential analyses, we identified xQTL associations putatively relevant to lifetime 
PTSD.  All tables summarizing results for each set of PTSD-relevant associations are in 
Appendix C.   
Among the effective set of SNP-GE associations, we identified 28 eQTL associations 
differentially expressed by lifetime PTSD.  Of these, 18 were newly detected after accounting for 
SNP and 10 were detected in standard DE analysis even without accounting for SNP.  Two of the 
differentially expressed genes, FAM198B and AHSA2, were associated with a secondary SNP 
with the opposite direction of effect from lead SNP (i.e., associated with two SNPs of opposing 
effects on GE), supporting more complex regulatory mechanism for these genes.  Additionally, 
none of the SNPs were suggestively associated with lifetime PTSD based on genetic association 
tests.   
Among effective set of SNP-CpG associations, we identified 804 meQTL associations 
that putatively regulate CpGs associated with lifetime PTSD.  Of these, 20 were also detected in 
cell-type specific DM analysis without accounting for SNP while the majority were newly 
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detected after accounting for SNP.  Additionally, 46 CpGs were associated with two SNPs of 
opposing effects on CpG methylation levels and 15 SNPs suggestively associated with lifetime 
PTSD based on genetic association tests.   
Among the set of 356 CpG-GE associations, there were 3 PTSD-relevant CpG-Gene 
associations (eQTM; Table 4.2).  One eQTM independent of SNPs (i.e., not associated with 
eQTLs or meQTLs, n = 249) showed a positive association (corrected β = 0.28, eCpG p = 8.1e-4, 
eGene p = 0.039, r = 0.41) between cg12324708 and LYRM7, a significant DE gene.  Cell-type 
specific DM analyses supported cg12324708 to be hypermethylated in CD8+ T cells by lifetime 
PTSD status.  Additionally, based on HM450K annotation, cg12324708 is located in a cell-
specific differentially methylated region (cDMR).   
A negative eQTM association (corrected β = -0.32, eCpG p = 7.6e-4, eGene p = 0.038, r 
= -0.44) between cg22801149 and VRK3 was identified and both CpG and GE were significantly 
associated with lifetime PTSD after accounting for SNP.  Expression levels for VRK3 was also 
significantly associated with lifetime PTSD in standard DE analysis without accounting for SNP.  
Additionally, cg22801149 - VRK3 was associated with 49 SNPs (SNP-CpG-Gene associations) 
and had different lead SNPs for eQTL (rs113293707) and meQTL (rs4009626).   
A positive eQTM association (corrected β = 0.46, eCpG p = 1.0e-5, eGene p = 0.001, r = 
0.50) between cg09251680 and SACM1L was identified as PTSD-relevant: cg09251680 was 
associated with lifetime PTSD after accounting for its meQTL and SACM1L was not associated 
with any SNP but found to be significant in standard DE analysis.   
Finally, while not identified as a significant eQTM association, two e/meQTLs (i.e., 
SNPs associated with both CpG and GE), rs12310416 and rs6488618, were associated with both 
122 
 
cg23793961 and CLEC4C.  Both cg23793961 and CLEC4C were associated with PTSD after 
accounting for SNP.   
 
Cross-tissue overlap of PTSD-relevant eQTL/meQTL associations between blood and brain 
PTSD-relevant associations were checked against previously published associations in 
relevant brain regions (i.e., hippocampus and frontal/temporal cortex)364,365.  While there was no 
cross-tissue overlap for eQTM associations, there were a number of PTSD-relevant eQTL and 
meQTL associations shared between blood and brain regions or in linkage disequilibrium with 
reported associations in brain.   
Notably, there were 5 significant eQTL associations (Table 4.3) in both the frontal and 
temporal cortex that overlapped with the PTSD-relevant SNP-CpG-Gene associations identified 
in blood for VRK3.  An eQTL for CEP192, identified to be PTSD-relevant in blood, was also 
detected in temporal cortex.  Among meQTLs identified to be PTSD-relevant in blood, one 
overlapped with temporal cortex (rs10496439 - cg08023751) and 17 meQTLs overlapped in 
hippocampus (Table 4.4).   
 
4.5 Discussion 
In this study we conducted a preliminary investigation of the gene regulatory mechanisms 
underlying PTSD, specifically in African-Americans (AA) – an understudied, at-risk population.  
We identified a putatively causal SNP variant, rs151835, mediated by DNA methylation levels at 
cg13012653.  Both the SNP and CpG site are located in the CAST gene on chromosome 5 and, 
based on SCREEN ENCODE379, in candidate cis-regulatory elements (ccRE; EH37E1250073, 
EH37E1250077).  The CAST gene, which encodes calpastatin, was located within the 
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topologically associated domain (TAD) for both ccREs.  As TADs are largely invariant across 
different cell types380, this is suggestive of shared regulatory mechanisms.  Using a recently 
available resource381, we found the CpG in this meQTL, cg13012653, to have significantly 
correlated methylation levels between blood and brain (rho =  0.6, p = 0.044), suggesting its 
utility for inferring brain CpG levels using blood CpG levels.  Notably, calpastatin inhibits 
calpain, which has been implicated in a number of neurodegenerative disorders and is believed to 
play a role in neuronal death382.  Of note, rs151835 specifically has been associated with 
Parkinson’s disease in two independent datasets382.   
In addition to this suggestively causal meQTL, we sought to identify other PTSD-
relevant associations based on differential methylation or expression of associated CpG or 
Genes.  As mentioned, SNPs that do not endorse a causal effect on PTSD themselves may still be 
relevant for regulating CpGs and gene expression levels (GE) involved in the pathophysiology of 
PTSD.  Although not detectable in our model, it is possible that the association of SNP with 
PTSD was not detected/hidden because our model did not account for expected interaction 
effects with relevant experience-related variables, such as childhood maltreatment or trauma 
burden.  Here, we focused on identifying differential methylated CpGs and differential expressed 
genes by informing DM and DE models of the SNP as a covariate.  We identified a number of 
DM CpGs and DE genes that were not identified without accounting for the meQTL/eQTL SNPs 
respectively.  Notably, one specific set of 49 e/meQTLs was also identified as an eQTM, 
cg22801149-VRK3, where both CpG and GE were differentially methylated and expressed.  Five 
of the participating eQTL associations were also identified in both the temporal and frontal 
cortical brain regions.  The VRK3 gene encodes a member of the vaccinia-related kinase (VRK) 
family of serine/protein kinases, is widely expressed in tissues, and has previously been 
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implicated in autism spectrum disorders; mice deficient in VRK3 were shown to exhibit autism-
like behavior, with decreased dendritic spine number and arborization in the hippocampus383.   
In addition to the eQTLs for VRK3 that overlapped between blood and brain cortical 
tissue (frontal/temporal), we identified another PTSD-relevant eQTL and 18 meQTLs in blood 
that also had parallel eQTL and meQTLs identified in hippocampus and temporal cortex.  
Recently, a report produced a map of systemic interindividual variation of methylation levels at 
CpGs and showed that methylation levels in one tissue can predict expression for associated 
genes in other tissues363.  Further investigation of the genomic context and region for this list of 
associations, including TADs, CpG methylation level correlation between blood and brain, will 
help identify what inferences can be made in relevant brain regions.  Since genomic variants are 
constant across tissue, PTSD-relevant eQTLs/meQTLs that overlap between brain and blood 
may provide a shared genetic regulatory mechanism by which CpGs/genes in leukocytes may be 
correlated with those in brain.  It is also important to keep in mind that the PTSD-relevant 
associations that we have identified and characterized provide only a glimpse of the gene 
regulatory context involved in PTSD.  The complexities of regulatory mechanisms pose 
modeling challenges and cross-omic associations are not expected to be linear in many contexts.  
For example, the relationship between CpGs and gene expression are dependent on genomic 
context and have been found to be non-linear outside of classical promoter regions (eg., TSS, 
first exon, 3’ end)384.   
Since sample size and, relatedly, use of one cohort, were major limitations of our study, 
we utilized integrative approaches and relied on convergence of evidence across multiple sets of 
analyses to support our findings.  In all, our preliminary investigation of the gene regulatory 
mechanisms underlying PTSD in African-Americans (AA) provides proof of concept for the 
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implementation of an integrative genomic approach to identify candidates that may be used for 
blood-brain inference.  Most notably, we found a causal variant in the CAST gene putatively 
mediated via DNA methylation that may have significant correlation between blood and brain.  
While this variant was not found to have different allele frequencies in African ancestry 
populations, implementing a population-specific approach is necessary for identifying 
functionally relevant population differences in gene regulatory mechanisms.   Given the 
profound impact and implications of these population differences, our African ancestry-specific 
study seeks to lessen the gap in knowledge implicated in health disparities.  Further examination 
of allele frequencies, putative population differences, and mechanistic inferences are warranted 
for the candidate PTSD-relevant eQTL and meQTLs shared between key brain regions and 
blood.  Continued work investigating these preliminary results require replication in other data 





4.6 Figures and Tables 
 





Figure 4.2. Candidate causal meQTL (rs151835) mediated by cg13012653.  
Violin plot (left) for adjusted beta-values at cg13012653 in trauma-exposed controls (blue) and lifetime PTSD cases (red), by rs151835 genotype.  
Table (top right) shows proportion of genotypes by PTSD status (i.e., trauma-exposed controls and lifetime PTSD cases).  Density plot (bottom 
right) shows distribution of adjusted beta-values at cg13012653 for each PTSD group.  PTSD cases are more likely to have the G/G genotype at  
rs151835 and lower methylation levels at cg13012653.  Beta-values are adjusted for sex, age, current smoking, and leukocyte proportions (based 






Figure 4.3. Effect Plot for Causal Mediation Analysis: rs151835 - cg13012653.  
Effect estimates with 95% confidence intervals (non-parametric bootstrap) are shown for average causal mediation effect (ACME), average direct 
effect (ADE) and total effect of model 1, comparing control genotype (0 minor alleles) to 1 minor allele (left), and model 2, comparing 0 vs 2 
minor alleles.  ACME and ADE estimates for treatment group (i.e., lifetime PTSD) are shown by the solid line and estimates for control group 





Table 4.1: Initial causal inference test results for significant CIT meQTL (rs151835 - cg13012653) 
 
model p_cit p_TassocL p_TassocGgvnL p_GassocLgvnT p_LindTgvnG SNP CpG 
1 0.026 0.021 0.026 2.54E-05 0.001 rs151835 cg13012653 
2 0.045 0.005 0.045 2.70E-07 0.002 rs151835 cg13012653 
Note: Model 1 does not include ancestry PCs as a covariate, while Model 2 does.  In meQTL-based CIT models, lifetime PTSD is the 
trait/outcome of interest (T), tested SNP is the locus/instrumental variable (L), and test CpG is the potential causal mediator (G).   
p_cit: CIT (omnibus) p-value.  Significance suggests mediation of causal effect of SNP on lifetime PTSD via CpG.   
p_TassocL: component p-value for test of association between PTSD (T) and SNP (L) 
p_TassocGgvnL: component p-value for test of association between PTSD (T) and CpG levels (G), given SNP (L) 
p_GassocLgvnT: component p-value for test of association between CpG levels (G) and SNP (L), given PTSD (T) 
p_LindTgvnG: component p-value for equivalence test of SNP (L) independent of PTSD (T) given CpG (G) 
 
Table 4.2: PTSD-relevant eQTM associations 
 
Gene CpG statistic Nominal β Corrected β nominal pval CpG pval Gene pval SE (β) r 
LYRM7 cg12324708 4.48 0.41 0.28 2.07E-05 8.07E-04 0.039 0.063 0.41 
VRK3 cg22801149 -4.89 -0.44 -0.32 4.01E-06 7.61E-04 0.038 0.066 -0.44 








Table 4.3: PTSD-relevant eQTL associations shared between blood and brain  
 
SNP Gene Chr Brain Region Ref 
rs12978378 VRK3 19 fctx; tctx Gibbs 
rs12984158 VRK3 19 fctx; tctx Gibbs 
rs12609054 VRK3 19 fctx; tctx Gibbs 
rs12611411 VRK3 19 fctx; tctx Gibbs 
rs12978357 VRK3 19 fctx; tctx Gibbs 
rs11663049 CEP192 18 tctx Gibbs 
 
fctx: frontal cortex 
tctx: temporal cortex 
 
Brain Reference: Gibbs et al. (2010)364 
 
 
Table 4.4: PTSD-relevant meQTL associations shared between blood and brain  
 
SNP CpG Associated Gene Chr Brain Region Ref 
rs10496439 cg08023751 MERTK 2 tctx Gibbs 
rs17674346 cg25716820 CELF5 19 hippo Schulz 
rs4640536 cg10954944 TRNA_Asp 3 hippo Schulz 
rs2526748 cg05623727 RBM5 3 hippo Schulz 
rs2856234 cg05623727 RBM5 3 hippo Schulz 
rs10897276 cg00685014 SCGB1A1 11 hippo Schulz 
rs9970286 cg15591803 DENND2D 1 hippo Schulz 
rs6573939 cg26146732 ADAM21P1 14 hippo Schulz 
rs2287783 cg00339695 SLC5A11 16 hippo Schulz 
rs11607954 cg17139436 KRTAP5-6 11 hippo Schulz 
rs10897276 cg16509239 SCGB1A1 11 hippo Schulz 
rs6907558 cg26242687 DQ141194 6 hippo Schulz 
rs2247114 cg21159260 BC013821 5 hippo Schulz 
rs7765522 cg06139720 IPCEF1 6 hippo Schulz 
rs7213791 cg21287519 SGSM2 17 hippo Schulz 
rs1205259 cg25302603 PCNXL3 11 hippo Schulz 
rs2883956 cg21191810 CEP85L 6 hippo Schulz 
rs10223063 cg18373318 SNX18 5 hippo Schulz 
 
tctx: temporal cortex 
hippo: hippocampus 
 






CHAPTER 5: CONCLUSION 
 
5.1 General Discussion 
This body of work used genomic approaches to generate mechanistic hypotheses 
regarding dysregulation observed in post-traumatic stress disorder (PTSD), with a focus on 
characterizing sources of heterogeneity that are known to underlie the pathophysiology 
associated with the disorder.  It characterized both methylomic and transcriptomic profiles that 
reflect the pathophysiology of PTSD, in both brain and blood, and explored the genomic and 
epigenomic players underlying leukocyte transcriptomic profiles in PTSD to gain systems-level 
insights into sex-, ancestry-, and tissue-specific mechanisms involved in this disorder.   
 A major overarching theme is the significance of cellular heterogeneity in methylomic 
and transcriptomic profiles.  While epigenomic and transcriptomic studies have focused on the 
identification of dynamic differential methylation marks and transcriptional activity, 
respectively, understanding changes in cellular composition provide key insights and warrant 
examination themselves.  In our first study, we leveraged a recently developed methods in cell 
deconvolution approach for DNA methylation-based immune profiling of lifetime PTSD and 
found higher monocyte proportions in males, but not females with a lifetime history of PTSD.  In 
our second study, we leveraged recently developed brain cell reference dataset to uncover higher 
levels of hippocampal oligodendrocytes in the PTSD-like group compared to the resilient or 
unexposed group in a rat model of PTSD.  While this finding of increased hippocampal 
oligodendrocytes is shared between sexes, profound sex differences in cell composition was 
revealed in amygdala.  Accounting for cell composition we further identified both sex-specific 
and shared networks of transcriptional activity associated with individual differences in stress 
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response.  Together, this discovery of sex-specific differences in leukocyte composition and sex-
specific gene networks of transcriptional activity in brain highlight the importance of 
approaching sex as more than a covariate in the study of PTSD.   
 The second theme considers the relationship between blood and brain.  While PTSD is 
defined by behavioral/cognitive symptoms most directly relevant to brain function, it can be 
considered a systemic disorder characterized by a distinct inability to reinstate homeostasis after 
trauma.  In our second study investigating expression profiles of blood, amygdala, and 
hippocampus, we found the common subject shared across blood and brain actually 
characterized the resilient, rather than the PTSD-like, response to stress: the resilient group was 
characterized with increased wound healing response in blood and increased ECM 
reorganization in both brain regions.  An overarching set of pathways disrupted in PTSD was 
identified across amygdala and hippocampus as well.  Across these key limbic regions, we found 
PTSD-like response to stress to involve disrupted TNFα/NFκΒ signaling and 
excitatory/inhibitory imbalance in dysregulated synaptic/structural plasticity with important 
implications for fear learning and memory.  Our third study approached the blood-brain topic 
from a gene regulatory context.  DNA methylation levels (CpG) and gene expression levels (GE) 
are often cell-specific, but genetic variants, such as single nucleotide polymorphisms, (SNPs) are 
not.  Thus, CpG and GE regulated by SNPs have an “anchor” to base inferences of CpG and GE 
across blood and brain.  Most notably, we identified a putatively causal SNP, rs151835, in the 
CAST gene mediated by DNA methylation levels at cg13012653, which is suggested to be 
correlated between blood and brain.  Additionally, we identified a subset of PTSD-relevant SNP-
CpG and SNP-GE associations shared between blood and key brain regions that require further 
investigation.   
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 On the other side of the coin, although PTSD is moderately heritable, robust replicable 
genetic variants have eluded detection due to challenges managing heterogeneity and gene-
environment interactions.  Ancestry-specific investigation implementing an integrative systems 
level approach can help characterize regulatory contexts for genetic variants and epigenetic 
marks.  Our last study conducted a preliminary investigation of the gene regulatory mechanisms 
underlying PTSD, specifically in African-Americans (AA) – an understudied, at-risk population.  
While our primary causal SNP candidate in the CAST gene was not found to have different allele 
frequencies in African ancestry populations, implementing a population-specific approach is 
necessary for identifying functionally relevant population differences in gene regulatory 
mechanisms.  Given the profound impact and implications of these population differences, our 
African ancestry-specific study sought to lessen the gap in knowledge implicated in health 
disparities.   
While this work is informative for understanding how trauma exposure precipitates a 
distinct physiological state in vulnerable individuals, future work that associates genomic 
profiles with symptom clusters rather than PTSD diagnosis may provide better resolution 
insights into pathways specifically associated with individual PTSD symptom clusters.  
Expanding on this, a transdiagnostic symptom cluster approach may further help disentangle the 
substantial heterogeneity and co-morbidity observed among stress-related disorders 385 by 
providing intermediate phenotypes more closely associated with biological processes than 
diagnostic categories.  In fact, the National Institute for Mental Health (NIMH) recognized the 
need for a paradigm shift in psychiatric nosology from being based on descriptive, clinical 
observations to pathophysiology informed largely by clinical neuroscience and genomics 
research386-388.  To support the eventual development of such a diagnostic system, the NIMH 
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launched the Research Domain Criteria (RDoC) initiative, which provides a research 
classification framework whereby multi-level, multidimensional data can be leveraged to 
understand the biological basis of behavioral/cognitive domains dysregulated in mental 
disorders386-389.   
Applying the RDoC framework to longitudinal studies that investigate symptoms and 
physiological states, in the context of genetics, life experiences/exposures, and sociocultural 
context, over a life course390, will enable us to understand the role of each determinant in 
influencing mental health trajectories and to discern biological correlates that reflect pre-existing 
risk factors from those that occur as a response to trauma at different clinical stages of 
PTSD213,391.  Ultimately, the hope is that our improved mechanistic understanding will lead to 
the discovery of robust predictive biomarkers that can be used for implementing early 
intervention and development of improved preventive and therapeutic strategies that cater to 
individual differences, including sex/gender- and ancestry/ethnic- specific considerations.  This, 
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APPENDIX A: SUPPLEMENTARY MATERIALS – CHAPTER 2 
 
I. Results for main analyses, based on CP estimates 
II. Supplementary Figures and Tables for CP-based results of main analyses 
III. Comparison of leukocyte subtype proportions between participating cohorts 
IV. Assessment of age effects, including supplementary figures 
 
I. Results for main analyses, based on CP estimates 
A second set of cell estimates, derived using the popular constrained projection (CP) 
deconvolution approach, were compared against robust partial correlation (RPC) based cell 
estimates.  Results from analyses conducted on both sets of cell estimates were checked for 
agreement.  The main text details findings based on RPC estimates and this supplementary 
materials section describes corresponding findings based on CP estimates.   
Comparison of leukocyte subtype estimates by sex, lifetime PTSD, and study using CP estimates 
As observed in RPC estimates, there were significant sex differences in CP-based 
distributions of both NK (KS: D = 0.21, adj p = 0.001) and CD8T (KS: D = 0.25, adj p = 
4.21×10-5) cell estimates, with males again showing greater variability than females for both NK 
and CD8T cells (male vs. female - IQRNK: 7.3% vs. 5.2%; IQRCD8T: 6.4% vs. 5.1%).  
Additionally, there were higher median NK (5.0% vs. 2.9%) and lower median CD8T (11.6% vs. 
13.5%) cell proportions in males compared to females (Figure A.1).  Again, no significant 
overall differences (i.e., in both sexes combined) were observed between lifetime PTSD cases 
and trauma-exposed controls in any leukocyte subtype (Mann-Whitney).   
160 
 
CP estimates confirm male-specific association between lifetime PTSD and DNAm-based 
monocyte proportions 
As observed previously, males with lifetime PTSD had higher monocyte proportions than 
trauma-exposed controls, U = 2200, Z = -2.5, p = 0.01, r = 0.20, while no difference was found 
between PTSD cases and controls in females, U = 13000, Z = -0.15, p = 0.88, r = 0.008 (Figure 
A.2).  A two-way ANCOVA on square root transformed CP-based estimates, accounting for age, 
ancestry, and current smoking (Table A.1), showed a significant interaction between sex and 
lifetime PTSD, F(1,461) = 3.99, p = 0.046, ηp
2 = 0.009.  Post-hoc comparison of EMMs by sex 
(Figure A.3; Table A.2) confirmed a significant mean difference between lifetime PTSD cases 
and controls in males, with higher mean monocyte estimates in PTSD cases, ∆EMM = 0.24, SE = 
0.09, t(461) = 2.85, p = 0.005.  Again, no significant mean difference between PTSD cases and 
controls was found in females, ∆EMM = 0.04, SE = 0.06, t(461) = 0.63, p = 0.53.  Smaller 
difference in EMM (∆EMM) and larger EMM standard error were observed in male CP 
estimates, compared to RPC estimates.   
Finally, sex-stratified Kruskal-Wallis tests for PTSD status using CP-based monocyte 
estimates (Figure A.4) also suggested significant differences in males, H(2) = 6.5, p = 0.038, but 
not females, H(2) = 0.74, p = 0.69.  While no difference was observed between current and 
remitted PTSD groups, Z = 0.24, p = 0.81, adj. p = 0.81, r = 0.03, in the post-hoc Dunn test, 
differences between PTSD cases and trauma-exposed controls showed smaller effect sizes and 
only nominal significance (current PTSD vs controls: Z = 2.11, p = 0.035, adj. p = 0.10, r = 




II. Supplementary Figures and Tables for CP-based results of main analyses 
Figure A.1: Distribution of leukocyte subtypes based on constrained projection (CP) estimates, by sex.  As noted in RPC estimates, sex 




Figure A.2: Density plots for CP monocyte estimates in lifetime PTSD cases and controls, stratified by 
sex, show distinctly higher monocyte levels in males with lifetime PTSD compared to trauma-exposed 
cases.  This difference in monocyte levels between lifetime PTSD case and controls is not observed in 













Figure A.3: Lifetime PTSD by sex interaction plot for estimated marginal means (EMMs) of CP 
monocyte estimates.  Interaction plot shows a significant EMM difference between lifetime PTSD cases 
(red) and controls (blue) in males, where mean monocyte estimates are higher in cases than controls.  No 







Figure A.4: Density plots for CP monocyte estimates comparing those with current PTSD, remitted 
PTSD, and trauma-exposed controls, stratified by sex.  No significant difference is observed between 
current and remitted PTSD cases, which suggests that the significant difference  in male PTSD cases is 
associated with long-standing PTSD trait, rather than current PTSD state.  However, unlike RPC-based 
estimates, difference between PTSD case groups and trauma-exposed controls was only nominally 










Table A.1: Two-way ANCOVA Table for CP monocyte estimates (n = 469) 
  
Terms 
Type III Sum 
of Squares 
df Mean Square F p partial η
2 
Sex 0.034 1 0.034 0.130 0.719 0.000 
PTSDlife 1.929 1 1.929 7.256 0.007** 0.015 
Age 2.964 1 2.964 11.150 0.001*** 0.024 
ancPC1 0.036 1 0.036 0.137 0.712 0.000 
ancPC2 0.063 1 0.063 0.236 0.627 0.001 
Smoking 0.000 1 0.000 0.000 0.987 0.000 
Sex:PTSDlife 1.060 1 1.060 3.987 0.046* 0.009 
Residuals 122.555 461 0.266 
   








Table A.2: Summary for CP monocyte estimates by group 
Sex PTSD n mean SE EMM SEEMM lower.CL upper.CL 
Female no 135 6.564 0.2499 6.186 0.2285 5.745 6.643 
Female yes 184 6.551 0.1735 6.373 0.1946 5.996 6.761 
Male no 70 6.072 0.3165 5.772 0.2972 5.203 6.371 
Male yes 80 7.270 0.3248 7.004 0.3106 6.407 7.628 
 
This table describes untransformed CP monocyte estimates by group (i.e., sex and lifetime PTSD); 
n = count per group; EMM = estimated marginal means (i.e., least squares means); SE = standard errors 
for regular means; SEEMM = standard errors for EMM. 
 
Lower and upper confidence limits are for 95% level.  EMM and intervals were back-transformed from 
the square root scale to the original scale of cell subtype proportions (%).  Significance level of alpha = 
0.05 was used for EMM comparisons.  Results for pairwise comparison were averaged over levels for 
current smoking.  Degree of freedom was 461 and male lifetime PTSD cases were significantly different 






III. Comparison of leukocyte subtype proportions between participating cohorts 
We assessed study differences in leukocyte subsets using Mann-Whitney U test (Holm-
adjusted p < 0.05).  For RPC estimates, comparison between DNHS and GTP cohorts revealed a 
significant difference in median CD8T-cell proportions, U = 22,634, Z = -2.9, p = 0.003, adj. p = 
0.021, r = -0.13, in the overall dataset (both sexes), but not in sex-stratified subsets.  Similarly, 
comparison between DNHS and GTP cohorts using CP-based estimates revealed a significant 
difference in median CD8T-cell proportions, U = 22,739, Z = -2.9, p = 0.004, adj. p = 0.026, r = 
-0.13, in the overall dataset (both sexes), as observed using RPC estimates.  However, unlike 
RPC estimates, a significant study difference in CD8T-cell proportions was also observed in the 
male subset, U = 1,972, Z = -3.24, p = 0.001, adj. p = 0.007, r = -0.26.  Study differences were 
not observed for any other leukocyte subtype, in the overall or sex-stratified sets, for each set of 
cell estimates.   
These differences may reflect demographic differences between the DNHS and GTP 
cohorts, in our dataset.  Chi-squared test (simulated p-value, based on 2000 replicates) indicates 
that self-reported race has a trending association with cohort (χ = 5.42, p = 0.07), with GTP 
contributing more AA participants, and lifetime PTSD had a significant association with cohort 
(χ = 8.96, p = 0.003), with DNHS contributing fewer trauma-exposed controls.  Thus, to benefit 
from increase in sample size while placing less relevance on possible cohort differences, datasets 
were combined at the individual level before deriving estimates and conducting analyses on the 






IV. Assessment of age effects 
Spearman’s rank correlation was used to explore age effects in each leukocyte subtype, 
with proportion estimates based on RPC (Figure A.5) and CP (Figure A.6).  The direction of 
effect for each leukocyte subtype was consistent between RPC and CP estimates.  At Holm-
adjusted p < 0.05, we observed a small but significant decline in CD8T, ρs(481) = -0.19, adj p = 
0.0002, and CD4T , ρs(481) = -0.13, adj p = 0.015, cell proportions and a small but significant 
increase in monocyte , ρs(481) = 0.13, adj p = 0.015, proportions with age.  Correlation tests for 
age based on CP estimates were consistent with results based on RPC estimates.  For CP 
estimates, we also observed a small but significant decline in CD8T, ρs(481) = -0.16, adj p = 
0.002, and CD4T , ρs(481) = -0.12, adj p = 0.046, cell proportions and a small but significant 
increase in monocyte , ρs(481) = 0.14, adj p = 0.013, proportions with age.  Comparison of age 
effects from our DNAm-based estimates with a published study2, based on Coulter counter 
(complete blood cell count, CBC) and flow cytometry data, revealed age-related changes in 
CD8T and monocyte proportions to be consistent for the age group corresponding to our study 
(i.e., between adult and elderly group).  However, no significant change between adult and 
elderly groups for CD4T proportions was found in the published study.  Effect of age was 
consistent by sex and sex by age interaction was not endorsed for any cell subtype.  However, we 
observed the decrease of CD8T cell proportions by age was slightly greater in males (RPC: 
ρs(151) = -0.24; CP: ρs(151) = -0.23) than females (RPC: ρs(328) = -0.17; CP: ρs(328) = -0.15), 
using both RPC (Figure A.7) and CP estimates (Figure A.8).   
                                                 
2  Valiathan, R., Ashman, M. & Asthana, D. Effects of Ageing on the Immune System: Infants to 





Figure A.5: Effect of age on proportion of leukocyte subtypes, based on RPC.  Spearman’s correlation and nominal p-value are reported towards 
top of each scatter plot.  Significant decrease in CD8T and CD4T cells and significant increase in monocytes is detected with increasing age, at 




Figure A.6: Effect of age on proportion of leukocyte subtypes, based on CP.  Spearman’s correlation and nominal p-value are reported towards 
top of each scatter plot.  Similar to RPC, significant decrease in CD8T and CD4T cells and significant increase in monocytes is detected with 






Figure A.7: Sex-stratified effect of age on proportion of leukocyte subtypes, based on RPC.  Spearman’s correlation and nominal p-value are 







Figure A.8:  Sex-stratified effect of age on proportion of leukocyte subtypes, based on CP.  Spearman’s correlation and nominal p-value are 
reported towards top of each scatter plot, for each sex (female: orange; male: purple).     
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APPENDIX B: CEMITOOL REPORTS & GENE SET RESULTS – CHAPTER 3 
 
The supplementary zip file (“AppendixB_Chap3Results.zip”) includes results from 
network and gene set analyses for all tissues.  The main directory is organized by tissue.  
CEMiTool reports are located in the “CEMiTool Reports/” subdirectory for each tissue.  This 
html report generated using CEMiTool includes network analysis parameters, group associations 
for modules, barplots showing top gene set results in the GO collection, and interaction 
networks.  Gene set enrichment results for all MSigDB collections associated with each analysis 
(e.g., full vs. sex-stratified, unadjusted vs. SV-adjusted vs. cell estimate adjusted) are included in 
their own subdirectories, with separate csv files for each module and gene set collection.  





APPENDIX C: SUPPLEMENTARY MATERIALS – CHAPTER 4 
 
The supplementary zip file (“AppendixC_Chap4Results.zip”) includes the tabulated set 
of results for PTSD-relevant xQTL associations, which are in separate .csv files.  A plain text 
README file located in the top directory contains the description for each .csv file.   
 
